Page last updated: 2024-08-21

dihydroergotamine and Migraine Disorders

dihydroergotamine has been researched along with Migraine Disorders in 280 studies

Research

Studies (280)

TimeframeStudies, this research(%)All Research%
pre-199075 (26.79)18.7374
1990's84 (30.00)18.2507
2000's56 (20.00)29.6817
2010's51 (18.21)24.3611
2020's14 (5.00)2.80

Authors

AuthorsStudies
Gommeren, W; Haegeman, G; Heylen, L; Lesage, AS; Leysen, JE; Luyten, WH; Schotte, A; Van de Weyer, I; Van Gompel, P; Vanhoenacker, P; Wouters, R1
Albrecht, D; Bérard, A; Kori, S; Strom, S; Zhao, JP1
Aurora, SK; Cooper, W; Davies, G; Fuller, C; Hoekman, J; Ray, S; Shrewsbury, SB1
Calabrò, RS; Casella, C; Militi, D; Raciti, G; Raciti, L1
Ailani, J; Aurora, SK; Hirman, J; Ray, S; Shrewsbury, SB; Tepper, SJ1
Chikkannaiah, M; Fonseca, LD; Goenka, A; Kumar, G1
Coric, V; Harris, L; L'Italien, G; Martin, T; Moren, JA; O'Connell, T; Woolley, JJ1
Aurora, SK; Mallick-Searle, T; Shrewsbury, SB; Starling, AJ1
Bickel, J; Boorigie, M; Connelly, M; Sekhon, S; Stephens, D1
Abdou, EM1
Hoekman, J; Shrewsbury, SB; Silberstein, SD1
Hershey, AD; Kabbouche, M; Maconochie, I; Murphy, B; Qaiser, S; Werner, K1
Cappa, R; Goodkin, HP; Mallawaarachchi, I; Mendoza, A; Samanta, D; Theroux, LM1
Greene, KA1
Freitag, FG1
Banga, AK; Eangoor, P; Joyce, JC; Knaack, JS; Nguyen, HX; Prausnitz, MR; Tas, C1
Patterson-Gentile, C; Szperka, CL1
Cook, CL; Shedd, GC1
Arslan, A; Esim, O; Kurbanoglu, S; Ozkan, CK; Ozkan, SA; Ozkan, Y; Savaser, A; Tas, C1
Evans, RW; Saper, JR1
Tfelt-Hansen, PC1
Lanteri-Minet, M1
Kori, SH; Silberstein, SD1
Chelimsky, G; Chelimsky, T; Raina, M1
Chow, SC; Douglas, PS; Kellerman, DJ; Kori, S; Mangum, B; Noveck, RJ1
Tepper, SJ1
Gupta, S; Oosthuizen, R; Pulfrey, S1
Tfelt-Hansen, P3
Diener, HC; Tfelt-Hansen, PC1
Becker, WJ2
Gerard, JM; Kaar, CR; Nakanishi, AK1
Evans, RW; Jankovic, J; Wijemanne, S1
Danesh, A; Grothusen, J; Pourrezaei, K; Pourshoghi, A; Tabby, DS1
Charles, A1
Eller, M; Gelfand, AA; Goadsby, PJ; Riggins, NY; Schankin, C; Shiboski, S1
Billinghurst, L; Crumley, ET; Durec, T; Hartling, L; Klassen, TP; Linsdell, MA; Richer, L; Russell, K; Vandermeer, B1
Blecha, J; Chou, DE; Eller, M; Goadsby, PJ; Hawkins, RA; Kori, S; Maniyar, FH; Murphy, ST; Schankin, CJ; Seo, Y; Sprenger, T; VanBrocklin, HF1
Chua, AL; Silberstein, S1
Bekan, G; Tfelt-Hansen, P1
Chou, DE; Goadsby, PJ; Tso, AR1
Meckler, GD; Sheridan, DC1
Cowan, RP; DeSouza, DD; O'Hare, M; Woldeamanuel, YW1
Goadsby, PJ; Ito, H; Robbins, NM; Scheinman, MM1
Kori, SH; Miller, SD; Pedinoff, A; Shrewsbury, SB; Weinstein, S1
Diener, HC; Schürks, M2
Friedman, BW; Friedman, MS; Hochberg, ML; Kapoor, A; Rowe, BH1
Biederman, S; Burdine, D; Hershey, AD; Kabbouche, MA; LeCates, S; Manning, P; Powers, SW; Segers, A; Vaughan, P1
Aurora, SK; Kori, SH; Rozen, TD; Shrewsbury, SB1
Schürks, M1
Autret-Leca, E; Beau-Salinas, F; Bensouda-Grimaldi, L; Cissoko, H; Jonville-Béra, AP1
Charles, JA; von Dohln, P1
FRIEDMAN, MD; WILSON, EJ1
POLLOCK, LA2
BLUMENTHAL, LS; FAKLER, B1
Taylor, FR1
Silberstein, SD2
Lovell, BV; Marmura, MJ1
Durham, PL; Masterson, CG1
DANNENBERG, T1
GOTTHELF, EJ1
FRIEDMAN, DA; FRIEDMAN, MD1
Galvez-Jimenez, N; Morren, JA1
Aurora, SK; Borland, SW; Dodick, DW; Kori, SH; Silberstein, SD; Tepper, SJ; Wang, M1
Rothrock, JF2
Callison, CR; Kumar, AB; Miller, M1
Cutrer, FM; Goadsby, PJ; Kori, SH; Silberstein, SD; Tepper, SJ; Wang, MH; Winner, PK1
Bhola, R; Gandhi, S; Goadsby, PJ; Nagy, AJ1
Borland, SW; Hu, B; Kori, SH; Mathew, NT; Silberstein, SD; Tepper, SJ; Wang, MH1
Chang, J; Dodick, D; Febbraro, S; Forst, A; Kellerman, D; Kori, S; Taylor, G; Thomas, T; Wutann, L1
Kelley, NE; Tepper, DE1
Derry, CJ; Derry, S; Moore, RA1
Peatfield, R1
Dahlöf, C; Maassen Van Den Brink, A1
Goadsby, PJ; Mathias, CJ; Viana, M1
Silberstein, S1
Gelfand, AA; Goadsby, PJ1
Csiba, L; Ficzere, A1
Aubel, B; Bourgoin, S; Hamon, M; Kayser, V1
Vaitkus, A; Vilionskis, A1
Banwart, L; Hurtado, TR; Vandenberg, JT; Vinson, DR1
Bigal, ME; Tepper, SJ1
McCrory, DC; Silberstein, SD1
Bell, WL; White, JR1
Etienne, N; Guesnier, L; Hickel, P; Maroteaux, L; Schaerlinger, B1
DALSGAARD-NIELSEN, T2
CARPI, A; VIRNO, M1
DRURY, JN1
PERSICHETTI, C1
HERSCHBERG, AD1
Allain, H; Delgado, A; Géraud, G; Lantéri-Minet, M; Lucas, C; Pradalier, A1
Lake, AE; Saper, JR; Swidan, SZ1
Andrews, PL; Cheng, FH; Moreaux, B; Ngan, MP; Rudd, JA; Sam, TS; Wai, MK; Wan, C1
Auvin, S; Cuvellier, JC; Joriot, S; Vallée, L1
Brown, MD; Colman, I; Grafstein, E; Innes, GD; Roberts, TE; Rowe, BH1
Josephs, KA; Stead, M1
Berger, MY; Bruijn, JK; Damen, L; Koes, BW; Passchier, J; Verhagen, AP1
Kabbouche, MA; Linder, SL1
Charles, JA; Jotkowitz, S1
Rozen, TD2
Saper, JR; Silberstein, S1
Dodick, D; Silberstein, S1
Dodick, D; Rapoport, A; Saper, JR; Silberstein, S1
Bradley, KC; Gebeline-Myers, C; Hopkins, MM; Silberstein, SD; Young, WB1
Gano, D; Gerretsen, P; Silver, S1
Nahas, SJ; Silberstein, SD1
Bhatt, A; Farooq, MU; Kassab, MY; Macfalda, B; Masih, A; Naravetla, B1
Huffmann, G1
Aylward, M; Chazot, G; Maddock, J; Schott, B1
Fanchamps, A; Müller-Schweinitzer, E1
Bono, G; Lanfranchi, M; Manna, V; Manzoni, GC; Martucci, N; Mattesi, P; Micieli, G; Troiani, G1
Conte, F; Fontanari, D; Perulli, L; Tambato, E; Toso, V; Zanetti, R1
Eggers, C1
Damasio, H1
Aylward, M; Davies, DE; Jones, M; Maddock, J; Robinson, PR1
D'Alessandro, R; Gamberini, G; Lozito, A; Sacquegna, T1
Iaccarino, C; Mastrosimone, F1
Albano, O; Attolini, E; Brucoli, C; Campanozzi, F; Centonze, V; Macinagrossa, G; Santoiemma, L1
Anselmi, B; Del Bianco, PL; Franchi, G; Panconesi, A; Sicuteri, F1
Saxena, PR; Spierings, EL2
Durko, A; Głuszcz-Zielińska, A1
Beubler, E1
Titus, F2
Alberca, R; Arenas, C; Casado, JL; Moreno, A; Serrano, V1
Ferrari, MD; Haan, J1
Scherl, ER; Wilson, JF1
Ferrari, MD; Gijsman, HJ1
Silberstein, SD; Young, WB1
Goadsby, PJ; Kaube, H1
Blumenthal, HJ; el-Raheb, M; Weisz, MA1
Wilkinson, M2
Lipton, RB; Silberstein, SD1
Kumar, KL1
Ford, R; Gallagher, RM; Hammerstad, J; Hoffert, M; Holtz, N; Kriegler, J; Peroutka, S; Saper, J; Vogel, B; Ziegler, D1
Dalessio, D; Mathew, N; Sadowsky, C; Sheftell, F; Silberstein, SD; Solomon, S; Turkewitz, LJ; Winner, P2
Landy, S; Lobo, BL1
d'Allens, H; Henry, P1
Doenicke, A; Hoernecke, R1
Solomon, GD1
Bax, WA; Ferrari, MD; Haan, J; Meijler, WJ; Timmerman, H; van Coevorden, RS1
Edvinsson, L; Goadsby, PJ1
Raskin, NH4
Peroutka, SJ1
Van Mil, JW1
Wheeler, SD1
Mathew, NT; Ravishankar, K; Sanin, LC1
Le Force, B; Margul, B; Ricalde, O; Saper, J; Winner, P1
Cajfinger, F; Guérard des Lauriers, A; Lacoste, JP; Peraudeau, P; Pradalier, A; Scheck, F1
Ashford, E; Bertin, L; Bès, A; Pilgrim, AJ; Touchon, J1
Couch, JR; Evans, MS; Ghobrial, MW; Naritoku, DK1
Cabiac, MD; Dubray, C; Humbert, H; Lavène, D1
Lucker, C; Mathew, NT; Tietjen, GE1
Lambert, G; Michalicek, J1
Crismon, ML; Dalmady-Israel, C; Fagan, SC; Gidal, BE; Graves, NM; Privitera, MD; Wagner, ML1
Catarci, T; Cerbo, R1
Gallagher, RM2
Becker, WJ; Hoag, J; Riess, CM1
Mathew, NT3
Lipton, RB1
Young, WB1
Hämäläinen, ML; Hoppu, K; Santavuori, PR1
Audinot-Bouchez, V; Chaput, C; Conte, C; Lavielle, G; Lochon, S; Millan, MJ; Newman-Tancredi, A; Verrièle, L1
Kaplan, B; Swain, RA1
Steurer, J1
Bax, WA; Ferrari, MD; MaassenVanDenBrink, A; Reekers, M; Saxena, PR1
Barton, CW; Carleton, SC; Chelly, JE; Chudnofsky, CR; Johnson, G; Morris, DL; Pietrzak, MP; Rhee, KJ; Rosenberg, J; Shesser, RF; Starkman, S; Van Valen, MK1
Delemazure, B; Rozot, P; Sommer, S; Wagner, M; Xenard, L1
Balda, BR; Hahne, T1
Filatova, EG; Solov'eva, AD; Veĭn, AM1
Kozma, CM; Lawrence, BJ; Payne, K1
Logemann, CD; Rankin, LM1
Bøe, MG; Monstad, P1
Lutz, G; Pradalier, A; Vincent, D1
Noth, J1
Ashford, E; Boureau, F; Esperanca, P; Kappos, L; Schoenen, J1
Krumholz, W; Menges, T; Ogal, H; Szalay, G1
Alchaar, H; Besson, G; Billé-Turc, F; Bouillat, J; Brudon, F; Donnet, A; Galletti, P; Gastaut, JL; Lantéri-Minet, M; Maitre, M; Moene, Y; Rambaud, G; Rostini, C; Valance, J1
Hargreaves, RJ; Williamson, DJ1
Steiner, TJ; Tfelt-Hansen, P1
Akhtar, ND; Murray, MA; Rothner, AD1
Winner, P1
Rothner, AD1
Yamane, K1
Hering, R; Korczyn, AD; Kuritzky, A; Treves, TA1
Ferrari, MD1
Autret, A; Mondon, K1
Henry, P1
Gupta, A; Rothner, AD1
Diamond, S; Wenzel, R1
Ullrich, J1
Fanchamps, A2
Heyck, H1
Fozard, JR1
Baust, W; Stürtzbecher, KH1
Berde, B1
Barolin, GS1
Diamond, S1
Edvinsson, L; Hardebo, JE; Owman, C; Svendgaard, NA1
Hackaday, J1
Miyazaki, T1
Schwalb, H1
Zicot, M1
Victor, DI; Welch, RB1
Herzberg, L; Lenman, JA1
Liaño, H1
den Boer, MO; Saxena, PR; Somers, JA1
Wallasch, TM1
Ollat, H1
Buzzi, MG; Moskowitz, MA2
Scott, AK1
Schulman, EA; Silberstein, SD1
Goldstein, J1
Deliganis, AV; Peroutka, SJ1
Goadsby, PJ; Jauslin, P; Lance, JW1
Ambrosone, L; Cianciulli, GM; Iaquinto, G; Rambaldi, M; Rotiroti, D1
Scott, G; Ward, TN1
Brown, AM; Kaumann, AJ; Patch, TL1
Bussone, G; Frediani, F; Grazzi, L; Mailland, F; Zanotti, A; Zappacosta, BM1
Klapper, JA; Stanton, JS1
Goadsby, PJ; Gundlach, AL1
Rosenberg, SB; Schulman, EA1
Arteaga Manjón-Cabez, R; Herranz Fernández, J; Lastra Martínez, L1
Bremgartner, MF; Jenzer, G1
Bell, R; Lee, MA; Montoya, D; Shuaib, A1
Cavanna, M1
Foley, KM; Hagen, N; Portenoy, RK1
Backonja, M; Beinlich, B; Dulli, D; Schutta, HS1
Soyka, D1
Kunkel, RS1
Bühling, M; Cruz, A; Seibel, K1
Bousser, MG; Massiou, H2
Prusiński, A1
Edmeads, JG1
Pfaffenrath, V; Reiter, M1
Beck, B; Daniel, H1
Bousser, MG; Chick, J; Fuseau, E; Soisson, T; Thevenet, R1
Gerber, WD; Langohr, HD; Mangold, R; Reinecke, M1
Aydin, N; Culcuoglu, A; Guvener, A; Karan, O; Tulunay, FC1
Stein, M1
Cauquil, J; Demarez, JP; Harmey, JL; Le Bastard, B; Neuman, M1
Callaham, M; Raskin, N1
Wörz, R1
Vajnorský, J1
Heuser, B; Middendorf, E1
Höchter, W; Ottenjann, R; Seib, HJ; Wörmann, B1
Alexander, K; Creutzig, A; Flöge, J; Kamin, K; Wagner, HH; Wannske, M1
Durward, WF1
Bresque, E; Lagoutte, F; Vérin, P; Vizdy, A1

Reviews

88 review(s) available for dihydroergotamine and Migraine Disorders

ArticleYear
Delivery of Dihydroergotamine Mesylate to the Upper Nasal Space for the Acute Treatment of Migraine: Technology in Action.
    Journal of aerosol medicine and pulmonary drug delivery, 2022, Volume: 35, Issue:6

    Topics: Administration, Inhalation; Administration, Intranasal; Dihydroergotamine; Humans; Mesylates; Migraine Disorders; Technology

2022
Chronic Migraine: A Narrative Review on the Use of Botulinum Toxin with Clinical Indications and Future Directions.
    Journal of integrative neuroscience, 2022, Aug-10, Volume: 21, Issue:5

    Topics: Antipsychotic Agents; Botulinum Toxins, Type A; Calcitonin Gene-Related Peptide; Dihydroergotamine; Headache; Humans; Migraine Disorders; Nasal Sprays; Quality of Life; Treatment Outcome; Tryptamines

2022
Variability in recurrence rates with acute treatments for migraine: why recurrence is not an appropriate outcome measure.
    The journal of headache and pain, 2022, Nov-22, Volume: 23, Issue:1

    Topics: Calcitonin Gene-Related Peptide Receptor Antagonists; Dihydroergotamine; Headache; Humans; Migraine Disorders; Outcome Assessment, Health Care

2022
INP104: a drug evaluation of a nonoral product for the acute treatment of migraine.
    Pain management, 2023, Volume: 13, Issue:5

    Topics: Dihydroergotamine; Drug Evaluation; Headache; Humans; Migraine Disorders

2023
Dihydroergotamine (DHE) - Then and Now: A Narrative Review.
    Headache, 2020, Volume: 60, Issue:1

    Topics: Analgesics, Non-Narcotic; Dihydroergotamine; History, 20th Century; History, 21st Century; Humans; Migraine Disorders

2020
Intravenous Migraine Treatment in Children and Adolescents.
    Current pain and headache reports, 2020, Jul-08, Volume: 24, Issue:8

    Topics: Administration, Intravenous; Adolescent; Akathisia, Drug-Induced; Anesthetics, Local; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Basal Ganglia Diseases; Child; Dexamethasone; Dihydroergotamine; Diphenhydramine; Dopamine Antagonists; Emergency Service, Hospital; Enzyme Inhibitors; Fluid Therapy; Glucocorticoids; Hospitalization; Humans; Hypnotics and Sedatives; Ketorolac; Lidocaine; Magnesium; Migraine Disorders; Prochlorperazine; Propofol; Valproic Acid; Vasoconstrictor Agents

2020
The Changing Landscape of Pediatric Migraine Therapy: A Review.
    JAMA neurology, 2018, 07-01, Volume: 75, Issue:7

    Topics: Adolescent; Adrenergic beta-Antagonists; Amitriptyline; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Calcium Channel Blockers; Child; Cognitive Behavioral Therapy; Dihydroergotamine; Dopamine Antagonists; Fluid Therapy; Glucocorticoids; Headache Disorders, Secondary; Humans; Magnesium; Migraine Disorders; Nerve Block; Topiramate; Tryptamines; Valproic Acid

2018
Oral methylergonovine maleate for refractory migraine and cluster headache prevention.
    Headache, 2013, Volume: 53, Issue:2

    Topics: Administration, Oral; Adult; Analgesics, Non-Narcotic; Cluster Headache; Dihydroergotamine; Female; Humans; Methylergonovine; Migraine Disorders

2013
Relatively slow and long-lasting antimigraine effect of dihydroergotamine is most likely due to basic pharmacological attributes of the drug: a review.
    Cephalalgia : an international journal of headache, 2013, Volume: 33, Issue:13

    Topics: Analgesics, Non-Narcotic; Dihydroergotamine; Humans; Migraine Disorders; Randomized Controlled Trials as Topic; Time

2013
What's new in the migraine attack treatment.
    Revue neurologique, 2013, Volume: 169, Issue:5

    Topics: Analgesics; Calcitonin Gene-Related Peptide Receptor Antagonists; Dihydroergotamine; Humans; Migraine Disorders; Pain Management; Receptor, Serotonin, 5-HT1F; Receptors, Serotonin; Serotonin Receptor Agonists; Sumatriptan; Transcranial Magnetic Stimulation

2013
Dihydroergotamine: a review of formulation approaches for the acute treatment of migraine.
    CNS drugs, 2013, Volume: 27, Issue:5

    Topics: Analgesics, Non-Narcotic; Animals; Chemistry, Pharmaceutical; Dihydroergotamine; Humans; MEDLINE; Migraine Disorders

2013
Orally inhaled dihydroergotamine: a review.
    Headache, 2013, Volume: 53 Suppl 2

    Topics: Administration, Inhalation; Administration, Oral; Analgesics, Non-Narcotic; Animals; Clinical Trials as Topic; Dihydroergotamine; Humans; Migraine Disorders; Nebulizers and Vaporizers

2013
Use of dihydroergotamine (DHE) should be restricted to no more than twice a week.
    Headache, 2014, Volume: 54, Issue:9

    Topics: Analgesics, Non-Narcotic; Dihydroergotamine; Headache Disorders, Secondary; Humans; Migraine Disorders

2014
Acute Migraine Treatment in Adults.
    Headache, 2015, Volume: 55, Issue:6

    Topics: Adult; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Caffeine; Dihydroergotamine; Drug Administration Schedule; Female; Humans; Male; Migraine Disorders; Pain Management; Serotonin Receptor Agonists; Treatment Outcome; Tryptamines

2015
Acute Migraine Treatment.
    Continuum (Minneapolis, Minn.), 2015, Volume: 21, Issue:4 Headache

    Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Dihydroergotamine; Humans; Migraine Disorders; Tryptamines; Vasoconstrictor Agents

2015
Drugs for the acute treatment of migraine in children and adolescents.
    The Cochrane database of systematic reviews, 2016, Apr-19, Volume: 4

    Topics: Acetaminophen; Adolescent; Analgesics, Non-Narcotic; Child; Dihydroergotamine; Humans; Ibuprofen; Migraine Disorders; Serotonin Receptor Agonists; Time Factors; Tryptamines

2016
Inhaled drug therapy development for the treatment of migraine.
    Expert opinion on pharmacotherapy, 2016, Volume: 17, Issue:13

    Topics: Administration, Inhalation; Animals; Dihydroergotamine; Humans; Loxapine; Migraine Disorders; Prochlorperazine

2016
Is the Generally Held View That Intravenous Dihydroergotamine Is Effective in Migraine Based on Wrong "General Consensus" of One Trial? A Critical Review of the Trial and Subsequent Quotations.
    Headache, 2016, Volume: 56, Issue:9

    Topics: Administration, Intravenous; Analgesics, Non-Narcotic; Dihydroergotamine; Humans; Migraine Disorders; Randomized Controlled Trials as Topic; Research Design

2016
[Pathophysiology of migraine and clinical implications].
    Schmerz (Berlin, Germany), 2008, Volume: 22, Issue:5

    Topics: Analgesics; Brain; Cortical Spreading Depression; Cyclooxygenase 2 Inhibitors; Dihydroergotamine; Humans; Meninges; Migraine Disorders; Migraine with Aura; Neural Pathways; Neuronal Plasticity; Nociceptors; Risk Factors; Serotonin; Serotonin Receptor Agonists; Spinal Nerve Roots; Trigeminal Nerve; Tryptamines; Vasodilation

2008
The relative efficacy of meperidine for the treatment of acute migraine: a meta-analysis of randomized controlled trials.
    Annals of emergency medicine, 2008, Volume: 52, Issue:6

    Topics: Analgesics, Non-Narcotic; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Dihydroergotamine; Humans; Ketorolac; Meperidine; Migraine Disorders; Randomized Controlled Trials as Topic

2008
Migraine, allodynia, and implications for treatment.
    European journal of neurology, 2008, Volume: 15, Issue:12

    Topics: Analgesics; Brain; Clinical Trials as Topic; Comorbidity; Cyclooxygenase Inhibitors; Dihydroergotamine; Humans; Hyperalgesia; Migraine Disorders; Trigeminal Nerve; Tryptamines

2008
Dihydroergotamine: role in the treatment of migraine.
    Expert opinion on drug metabolism & toxicology, 2009, Volume: 5, Issue:9

    Topics: Clinical Trials as Topic; Dihydroergotamine; Humans; Migraine Disorders

2009
Acute treatment of migraine headaches.
    Seminars in neurology, 2010, Volume: 30, Issue:2

    Topics: Acute Disease; Analgesia; Anti-Inflammatory Agents; Dihydroergotamine; Female; Humans; Male; Migraine Disorders; Neuropharmacology; Outcome Assessment, Health Care; Patient Education as Topic; Physician-Patient Relations; Tryptamines

2010
Meeting acute migraine treatment needs through novel treatment formulations.
    Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2010, Volume: 7, Issue:2

    Topics: Analgesics, Non-Narcotic; Diclofenac; Dihydroergotamine; Drug Administration Routes; Drug Delivery Systems; Drug Prescriptions; Humans; Migraine Disorders; Sumatriptan

2010
New therapeutic developments in chronic migraine.
    Current opinion in neurology, 2010, Volume: 23, Issue:3

    Topics: Analgesics; Anticonvulsants; Botulinum Toxins, Type A; Dihydroergotamine; Electric Stimulation Therapy; Headache Disorders; Humans; Migraine Disorders; Neuropharmacology; Preventive Medicine; Risk Factors

2010
Where is dihydroergotamine mesylate in the changing landscape of migraine therapy?
    Expert opinion on pharmacotherapy, 2010, Volume: 11, Issue:18

    Topics: Analgesics, Non-Narcotic; Animals; Dihydroergotamine; Female; Humans; Male; Migraine Disorders; Patient Satisfaction; Practice Guidelines as Topic; Quality of Life; Recurrence; Sex Factors

2010
Rescue therapy for acute migraine, part 1: triptans, dihydroergotamine, and magnesium.
    Headache, 2012, Volume: 52, Issue:1

    Topics: Acute Disease; Analgesics, Non-Narcotic; Dihydroergotamine; Humans; Magnesium; MEDLINE; Migraine Disorders; Tryptamines

2012
Sumatriptan (intranasal route of administration) for acute migraine attacks in adults.
    The Cochrane database of systematic reviews, 2012, Feb-15, Issue:2

    Topics: Acute Disease; Administration, Intranasal; Adult; Dihydroergotamine; Female; Humans; Male; Migraine Disorders; Pain Management; Randomized Controlled Trials as Topic; Serotonin 5-HT1 Receptor Agonists; Sumatriptan; Triazoles; Tryptamines

2012
Dihydroergotamine, ergotamine, methysergide and sumatriptan - basic science in relation to migraine treatment.
    Headache, 2012, Volume: 52, Issue:4

    Topics: Animals; Dihydroergotamine; Ergotamine; Humans; Methysergide; Migraine Disorders; Sumatriptan; Treatment Outcome

2012
MAP0004: dihydroergotamine mesylate inhalation aerosol for acute treatment of migraine.
    Expert opinion on pharmacotherapy, 2012, Volume: 13, Issue:13

    Topics: Administration, Inhalation; Animals; Dihydroergotamine; Dopamine Agonists; Drug Delivery Systems; Humans; Metered Dose Inhalers; Migraine Disorders; Pulmonary Alveoli; Vasoconstrictor Agents

2012
Treatment of pediatric migraine in the emergency room.
    Pediatric neurology, 2012, Volume: 47, Issue:4

    Topics: Adolescent; Age Distribution; Age of Onset; Analgesics; Antiemetics; Child; Child, Preschool; Dihydroergotamine; Disease Management; Dopamine Antagonists; Drug Therapy, Combination; Emergency Service, Hospital; Female; Fluid Therapy; Humans; Male; Metoclopramide; Migraine Disorders; Narcotics; Neuroimaging; Prevalence; Sex Distribution; Tryptamines; Valproic Acid; Vomiting

2012
[Treatment of migraine in patients with hypertension and ischemic heart disease].
    Ideggyogyaszati szemle, 2002, Jan-20, Volume: 55, Issue:1-2

    Topics: Adjuvants, Pharmaceutic; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Contraindications; Dihydroergotamine; Dopamine Agonists; Ergotamine; Humans; Hypertension; Indoles; Migraine Disorders; Myocardial Ischemia; Oxazolidinones; Retrospective Studies; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines; Vasoconstrictor Agents

2002
Ergotamine, dihydroergotamine: current uses and problems.
    Current medical research and opinion, 2001, Volume: 17 Suppl 1

    Topics: Analgesics, Non-Narcotic; Dihydroergotamine; Ergotamine; Humans; Migraine Disorders; Serotonin Receptor Agonists; Sumatriptan

2001
[The problems of migraine headache treatment].
    Medicina (Kaunas, Lithuania), 2002, Volume: 38, Issue:7

    Topics: Aged; Analgesics; Analgesics, Non-Narcotic; Aspirin; Dihydroergotamine; Female; Humans; Male; Methysergide; Migraine Disorders; Oxazolidinones; Serotonin Antagonists; Serotonin Receptor Agonists; Stress, Psychological; Sumatriptan; Time Factors; Tryptamines; Vasoconstrictor Agents

2002
Ergotamine and dihydroergotamine: a review.
    Current pain and headache reports, 2003, Volume: 7, Issue:1

    Topics: Dihydroergotamine; Dose-Response Relationship, Drug; Ergotamine; Humans; Migraine Disorders; Randomized Controlled Trials as Topic; Sumatriptan; Treatment Outcome

2003
Ergotamine and dihydroergotamine: history, pharmacology, and efficacy.
    Headache, 2003, Volume: 43, Issue:2

    Topics: Animals; Dihydroergotamine; Ergotamine; History, 19th Century; History, 20th Century; Humans; Migraine Disorders; Receptors, Serotonin; Treatment Outcome; United States; Vasoconstrictor Agents

2003
MT 300--POZEN: dihydroergotamine mesylate injection.
    Drugs in R&D, 2003, Volume: 4, Issue:6

    Topics: Dihydroergotamine; Humans; Migraine Disorders; Nausea; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists

2003
[Pharmacologic treatment of acute migraine attack in children].
    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2005, Volume: 12, Issue:3

    Topics: Acetaminophen; Acute Disease; Administration, Intranasal; Administration, Oral; Adolescent; Age Factors; Analgesics, Non-Narcotic; Biofeedback, Psychology; Child; Dihydroergotamine; Humans; Ibuprofen; Injections, Intravenous; Life Style; Migraine Disorders; Relaxation Therapy; Serotonin Receptor Agonists; Sumatriptan; Vasoconstrictor Agents

2005
Parenteral dihydroergotamine for acute migraine headache: a systematic review of the literature.
    Annals of emergency medicine, 2005, Volume: 45, Issue:4

    Topics: Adult; Antiemetics; Dihydroergotamine; Drug Therapy, Combination; Humans; Injections, Intravenous; Migraine Disorders; Randomized Controlled Trials as Topic

2005
Symptomatic treatment of migraine in children: a systematic review of medication trials.
    Pediatrics, 2005, Volume: 116, Issue:2

    Topics: Acetaminophen; Adolescent; Analgesics, Non-Narcotic; Child; Child, Preschool; Controlled Clinical Trials as Topic; Dihydroergotamine; Female; Humans; Ibuprofen; Ketorolac; Male; Migraine Disorders; Prochlorperazine; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Sulfonamides; Sumatriptan

2005
Management of migraine in children and adolescents in the emergency department and inpatient setting.
    Current pain and headache reports, 2005, Volume: 9, Issue:5

    Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Child; Dihydroergotamine; Dopamine Agents; Emergency Medical Services; Hospitalization; Humans; Migraine Disorders; Serotonin Receptor Agonists

2005
Acute therapy for migraine headaches.
    Seminars in neurology, 2006, Volume: 26, Issue:2

    Topics: Antipsychotic Agents; Dihydroergotamine; Humans; Migraine Disorders; Narcotics; Time Factors; Tryptamines

2006
Pharmacology of dihydroergotamine and evidence for efficacy and safety in migraine.
    Headache, 2006, Volume: 46 Suppl 4

    Topics: Analgesics, Non-Narcotic; Chronic Disease; Dihydroergotamine; Humans; Migraine Disorders

2006
Central sensitization theory of migraine: clinical implications.
    Headache, 2006, Volume: 46 Suppl 4

    Topics: Analgesics, Non-Narcotic; Animals; Cyclooxygenase Inhibitors; Dihydroergotamine; Humans; Migraine Disorders; Nociceptors; Trigeminal Caudal Nucleus

2006
DHE in the pharmacotherapy of migraine: potential for a larger role.
    Headache, 2006, Volume: 46 Suppl 4

    Topics: Analgesics, Non-Narcotic; Dihydroergotamine; Headache Disorders, Secondary; Humans; Migraine Disorders; Prevalence

2006
Acute treatment for migraine headache.
    Minerva medica, 2007, Volume: 98, Issue:1

    Topics: Adrenal Cortex Hormones; Barbiturates; Dihydroergotamine; Dopamine Antagonists; Humans; Migraine Disorders; Migraine with Aura; Tryptamines

2007
Acute treatment of paediatric migraine: a meta-analysis of efficacy.
    Journal of paediatrics and child health, 2008, Volume: 44, Issue:1-2

    Topics: Acetaminophen; Adolescent; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Child; Dihydroergotamine; Drug Evaluation; Humans; Ibuprofen; Migraine Disorders; Oxazolidinones; Placebos; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines

2008
[Migraine: dihydroergotamine nasal spray--an alternative].
    Wiener medizinische Wochenschrift (1946), 1995, Volume: 145, Issue:14

    Topics: Administration, Intranasal; Dihydroergotamine; Dose-Response Relationship, Drug; Humans; Metabolic Clearance Rate; Migraine Disorders; Treatment Outcome

1995
[Treatment of the acute migraine attack].
    Revista de neurologia, 1995, Volume: 23 Suppl 2

    Topics: Acute Disease; Dihydroergotamine; Ergotamine; Humans; Migraine Disorders; Serotonin Receptor Agonists; Sumatriptan; Vasoconstrictor Agents

1995
[Status migrainosus].
    Revista de neurologia, 1995, Volume: 23 Suppl 2

    Topics: Brain; Dihydroergotamine; Humans; Migraine Disorders; Serotonin Receptor Agonists; Sumatriptan; Vasoconstrictor Agents

1995
Acute treatment of migraine attacks.
    Current opinion in neurology, 1995, Volume: 8, Issue:3

    Topics: Adolescent; Adult; Analgesics; Child; Dihydroergotamine; Female; Humans; Male; Migraine Disorders; Pregnancy; Product Surveillance, Postmarketing; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Sumatriptan; Vasoconstrictor Agents

1995
Safety and efficacy of ergotamine tartrate and dihydroergotamine in the treatment of migraine and status migrainosus. Working Panel of the Headache and Facial Pain Section of the American Academy of Neurology.
    Neurology, 1995, Volume: 45, Issue:3 Pt 1

    Topics: Dihydroergotamine; Ergotamine; Humans; Migraine Disorders

1995
Migraine treatment: the British perspective.
    Headache, 1994, Volume: 34, Issue:8

    Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Dihydroergotamine; Ergotamine; Humans; Migraine Disorders; Sumatriptan; United Kingdom

1994
Overview of diagnosis and treatment of migraine.
    Neurology, 1994, Volume: 44, Issue:10 Suppl 7

    Topics: Adrenergic beta-Antagonists; Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Antidepressive Agents, Tricyclic; Calcium Channel Blockers; Dihydroergotamine; Ergotamine; Humans; Migraine Disorders; Serotonin Antagonists; Sumatriptan

1994
Recent advances in the acute management of migraine and cluster headaches.
    Journal of general internal medicine, 1994, Volume: 9, Issue:6

    Topics: Analgesics; Butorphanol; Capsaicin; Cluster Headache; Dihydroergotamine; Humans; Ketorolac; Metoclopramide; Migraine Disorders; Sumatriptan; Tolmetin

1994
Therapeutic advances in migraine.
    Journal of clinical pharmacology, 1993, Volume: 33, Issue:3

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Dihydroergotamine; Female; Humans; Indoles; Male; Migraine Disorders; Receptors, Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Sulfonamides; Sumatriptan; Valproic Acid

1993
Acute and prophylactic treatment of migraine: practical approaches and pharmacologic rationale.
    Neurology, 1993, Volume: 43, Issue:6 Suppl 3

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Dihydroergotamine; Ergotamine; Humans; Indoles; Migraine Disorders; Phenothiazines; Serotonin Receptor Agonists; Sulfonamides; Sumatriptan; Valproic Acid

1993
5-Hydroxytryptamine receptor subtypes and the pharmacology of migraine.
    Neurology, 1993, Volume: 43, Issue:6 Suppl 3

    Topics: Adenylyl Cyclases; Dihydroergotamine; Humans; Indoles; Migraine Disorders; Receptors, Serotonin; Serotonin Receptor Agonists; Sulfonamides; Sumatriptan

1993
Current developments in neurology, Part I: Advances in the pharmacotherapy of headache, epilepsy, and multiple sclerosis.
    The Annals of pharmacotherapy, 1996, Volume: 30, Issue:11

    Topics: Adjuvants, Immunologic; Administration, Intranasal; Administration, Oral; Anticonvulsants; Dihydroergotamine; Epilepsies, Partial; GABA Agonists; Humans; Injections, Spinal; Interferon beta-1a; Interferon beta-1b; Interferon-beta; Migraine Disorders; Multiple Sclerosis; Vasoconstrictor Agents

1996
The pharmacology of ergotamine and dihydroergotamine.
    Headache, 1997, Volume: 37 Suppl 1

    Topics: Analgesics, Non-Narcotic; Body Fluids; Dihydroergotamine; Ergotamine; Humans; Migraine Disorders; Receptors, Serotonin; Structure-Activity Relationship

1997
Dosing and administration of ergotamine tartrate and dihydroergotamine.
    Headache, 1997, Volume: 37 Suppl 1

    Topics: Analgesics, Non-Narcotic; Cluster Headache; Dihydroergotamine; Dosage Forms; Ergotamine; Humans; Migraine Disorders; Nausea; Suppositories; Tablets; Vomiting

1997
Ergotamine tartrate and dihydroergotamine mesylate: safety profiles.
    Headache, 1997, Volume: 37 Suppl 1

    Topics: Administration, Intranasal; Analgesics, Non-Narcotic; Animals; Consumer Product Safety; Dihydroergotamine; Drug Monitoring; Ergotamine; Humans; Migraine Disorders; Nausea; Product Surveillance, Postmarketing; Randomized Controlled Trials as Topic

1997
Serotonin 1D (5-HT1D) agonists and other agents in acute migraine.
    Neurologic clinics, 1997, Volume: 15, Issue:1

    Topics: Acute Disease; Analgesics, Non-Narcotic; Cluster Headache; Dihydroergotamine; Drug Interactions; Humans; Migraine Disorders; Recurrence; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Vasoconstrictor Agents

1997
Diagnosis, prophylaxis, and treatment of headaches in the athlete.
    Southern medical journal, 1997, Volume: 90, Issue:9

    Topics: Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents, Tricyclic; Chronic Disease; Cluster Headache; Dihydroergotamine; Female; GABA Agents; Headache; Humans; Male; Migraine Disorders; Nortriptyline; Physical Exertion; Psychomotor Performance; Recurrence; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Sports; Sumatriptan; Tension-Type Headache; Valproic Acid; Vasodilator Agents; Verapamil

1997
Newer intranasal migraine medications.
    American family physician, 2000, Jan-01, Volume: 61, Issue:1

    Topics: Administration, Intranasal; Administration, Oral; Analgesics, Non-Narcotic; Clinical Trials as Topic; Dihydroergotamine; Half-Life; Humans; Indoles; Migraine Disorders; Oxazoles; Oxazolidinones; Piperidines; Recurrence; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines

2000
Neurogenic inflammation in the context of migraine.
    Microscopy research and technique, 2001, May-01, Volume: 53, Issue:3

    Topics: Animals; Blood Proteins; Bosentan; Calcitonin Gene-Related Peptide; Capillary Permeability; Dihydroergotamine; Dura Mater; Humans; Migraine Disorders; Narcotics; Neurogenic Inflammation; Neurokinin-1 Receptor Antagonists; Pyrrolidines; Receptor, Serotonin, 5-HT1D; Receptor, Serotonin, 5-HT1F; Receptors, Neurokinin-1; Receptors, Serotonin; Serotonin Receptor Agonists; Skull; Sulfonamides; Sumatriptan; Trigeminal Nerve; Vasoconstrictor Agents; Vasodilation

2001
Triptans in childhood and adolescence.
    Seminars in pediatric neurology, 2001, Volume: 8, Issue:1

    Topics: Administration, Intranasal; Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Child; Clinical Trials as Topic; Dihydroergotamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Migraine Disorders; Serotonin Receptor Agonists; Treatment Failure; Vasoconstrictor Agents

2001
Complicated migraine and migraine variants.
    Seminars in pediatric neurology, 2001, Volume: 8, Issue:1

    Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Child; Diagnosis, Differential; Dihydroergotamine; Female; Humans; Male; Migraine Disorders; Sumatriptan

2001
[Migraine: selection of therapeutic agents to be applied during its attack].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2001, Apr-10, Volume: 90, Issue:4

    Topics: Analgesics; Antiemetics; Dihydroergotamine; Ergotamine; Humans; Migraine Disorders; Sumatriptan

2001
Treatment of childhood headaches.
    Current neurology and neuroscience reports, 2001, Volume: 1, Issue:2

    Topics: Acute Disease; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Child; Child, Preschool; Chronic Disease; Clinical Trials as Topic; Dihydroergotamine; Dopamine Antagonists; Double-Blind Method; Headache; Humans; Infant; Meninges; Migraine Disorders; Models, Theoretical; Patient Care Management; Prostaglandin Antagonists; Randomized Controlled Trials as Topic; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Tension-Type Headache; Trigeminal Nerve; Vasoconstrictor Agents

2001
Practical approaches to migraine management.
    CNS drugs, 2002, Volume: 16, Issue:6

    Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Analgesics, Opioid; Anesthetics, Local; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents; Clinical Trials as Topic; Dihydroergotamine; Humans; Migraine Disorders; Psychotropic Drugs; Secondary Prevention; Serotonin Receptor Agonists; Sumatriptan; Vasoconstrictor Agents

2002
The animal pharmacology of drugs used in the treatment of migraine.
    The Journal of pharmacy and pharmacology, 1975, Volume: 27, Issue:5

    Topics: Acetaminophen; Adrenergic alpha-Antagonists; Analgesics; Animals; Aspirin; Caffeine; Clonidine; Cyproheptadine; Dihydroergotamine; Ergotamine; Humans; Methysergide; Migraine Disorders; Monoamine Oxidase Inhibitors; Muscle, Smooth; Pizotyline; Serotonin Antagonists; Sympathetic Nervous System; Synaptic Transmission; Tryptamines; Vagus Nerve; Vasoconstrictor Agents; Vasodilator Agents

1975
[Classification, pathogenesis and drug therapy of migraine and related forms of headache].
    Die Medizinische Welt, 1975, Aug-29, Volume: 6, Issue:35

    Topics: Adrenergic beta-Antagonists; Animals; Caffeine; Clonidine; Dihydroergotamine; Drug Synergism; Epinephrine; Ergotamine; Headache; Histamine; Humans; Methysergide; Mice; Migraine Disorders; Norepinephrine; Pizotyline; Serotonin

1975
Pharmacology of ergot alkaloids in clinical use.
    The Medical journal of Australia, 1978, Nov-04, Volume: 2, Issue:3 Suppl

    Topics: Animals; Brain Diseases; Bromocriptine; Dihydroergotamine; Dihydroergotoxine; Dopamine Antagonists; Ergot Alkaloids; Ergotamine; Female; Humans; Methysergide; Migraine Disorders; Parkinson Disease; Pituitary Gland; Prolactin; Receptors, Adrenergic; Receptors, Dopamine; Uterus; Vasoconstriction

1978
[Current treatment of migraine].
    Revista clinica espanola, 1992, Volume: 191, Issue:3

    Topics: Adult; Child; Dihydroergotamine; Ergotamine; Female; Humans; Indoles; Male; Methysergide; Metoclopramide; Middle Aged; Migraine Disorders; Sulfonamides; Sumatriptan; Time Factors; Vasoconstrictor Agents

1992
[Drug-induced headache].
    Fortschritte der Neurologie-Psychiatrie, 1992, Volume: 60, Issue:3

    Topics: Analgesics; Analgesics, Opioid; Dihydroergotamine; Ergotamine; Headache; Humans; Migraine Disorders

1992
[Serotonin agonists and antagonists in migraine].
    Pathologie-biologie, 1992, Volume: 40, Issue:4

    Topics: Benzoxepins; Contraindications; Cyproheptadine; Dihydroergotamine; Ergotamine; Histamine H1 Antagonists; Humans; Indoles; Methysergide; Migraine Disorders; Phenothiazines; Pizotyline; Receptors, Serotonin; Sulfonamides; Sumatriptan; Vasoconstrictor Agents

1992
The trigemino-vascular system and migraine.
    Pathologie-biologie, 1992, Volume: 40, Issue:4

    Topics: Blood Proteins; Calcitonin Gene-Related Peptide; Cerebrovascular Disorders; Cranial Nerve Diseases; Dihydroergotamine; Dura Mater; Humans; Indoles; Migraine Disorders; Receptors, Serotonin; Substance P; Sulfonamides; Sumatriptan; Trigeminal Nerve; Vasoconstrictor Agents

1992
Dihydroergotamine: a review of its use in the treatment of migraine and other headaches.
    Clinical neuropharmacology, 1992, Volume: 15, Issue:4

    Topics: Dihydroergotamine; Headache; Humans; Migraine Disorders

1992
Symptomatic and prophylactic treatment of migraine and tension-type headache.
    Neurology, 1992, Volume: 42, Issue:3 Suppl 2

    Topics: Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Dihydroergotamine; Drug Therapy, Combination; Ergot Alkaloids; Headache; Humans; Migraine Disorders

1992
Ergot pharmacology and alternative delivery systems for ergotamine derivatives.
    Neurology, 1992, Volume: 42, Issue:3 Suppl 2

    Topics: Dihydroergotamine; Drug Administration Routes; Humans; Migraine Disorders

1992
[Flunarizine and dihydroergotamine in the treatment of migraine in children].
    Anales espanoles de pediatria, 1990, Volume: 32, Issue:3

    Topics: Age Factors; Child; Child, Preschool; Dihydroergotamine; Dose-Response Relationship, Drug; Flunarizine; Humans; Migraine Disorders; Parents

1990
Modern pharmacotherapy of migraine.
    Neurologic clinics, 1990, Volume: 8, Issue:4

    Topics: Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Chlorpromazine; Dihydroergotamine; Ergotamine; Humans; Migraine Disorders; Prochlorperazine; Valproic Acid

1990
[Therapy of headache].
    La Clinica terapeutica, 1989, Apr-30, Volume: 129, Issue:2

    Topics: Cluster Headache; Dextropropoxyphene; Dihydroergotamine; Domperidone; Ergotamine; Headache; Humans; Methysergide; Migraine Disorders; Pizotyline; Prednisolone; Prednisone; Vascular Headaches

1989
Pharmacologic management of migraine--1985.
    Cleveland Clinic quarterly, 1985,Spring, Volume: 52, Issue:1

    Topics: Adrenal Cortex Hormones; Adrenergic beta-Antagonists; Anti-Inflammatory Agents; Calcium Channel Blockers; Dihydroergotamine; Humans; Lithium; Lithium Carbonate; Methysergide; Metoclopramide; Migraine Disorders; Receptors, Adrenergic, alpha; Vasodilator Agents

1985
Monotherapy or polytherapy in migraine.
    Neuroepidemiology, 1987, Volume: 6, Issue:4

    Topics: Barbiturates; Clonidine; Dihydroergotamine; Drug Combinations; Humans; Migraine Disorders; Pizotyline

1987
Migraine.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 1988, Jan-15, Volume: 138, Issue:2

    Topics: Acute Disease; Adrenal Cortex Hormones; Adrenergic beta-Antagonists; Analgesics; Calcium Channel Blockers; Chlorpromazine; Dihydroergotamine; Ergotamine; Humans; Methysergide; Migraine Disorders; Narcotics; Pizotyline

1988
[Drug therapy of migraine].
    Wiener medizinische Wochenschrift (1946), 1988, Dec-31, Volume: 138, Issue:23-24

    Topics: Adrenergic beta-Antagonists; Analgesics; Antiemetics; Cerebrovascular Circulation; Dihydroergotamine; Humans; Locus Coeruleus; Methysergide; Migraine Disorders; Raphe Nuclei

1988

Trials

46 trial(s) available for dihydroergotamine and Migraine Disorders

ArticleYear
Assessing acute systemic effects of an inhaled drug with serial echocardiography: a placebo-controlled comparison of inhaled and intravenous dihydroergotamine.
    Drug design, development and therapy, 2013, Volume: 7

    Topics: Administration, Inhalation; Administration, Intravenous; Adolescent; Adult; Cross-Over Studies; Dihydroergotamine; Double-Blind Method; Echocardiography; Female; Humans; Male; Metered Dose Inhalers; Middle Aged; Migraine Disorders; Pulmonary Artery; Systole

2013
Randomized, double-blind, placebo-controlled study of the safety, tolerability and pharmacokinetics of MAP0004 (orally-inhaled DHE) in adult asthmatics.
    Current medical research and opinion, 2008, Volume: 24, Issue:7

    Topics: Administration, Inhalation; Administration, Oral; Adolescent; Adult; Analgesics, Non-Narcotic; Asthma; Dihydroergotamine; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Placebos

2008
A randomized, double blind, placebo-controlled study of MAP0004 in adult patients with migraine.
    Headache, 2009, Volume: 49, Issue:6

    Topics: Administration, Inhalation; Adolescent; Adult; Analgesics, Non-Narcotic; Dihydroergotamine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Pain Measurement; Time Factors; Treatment Outcome; Young Adult

2009
Outpatient home-based continuous intravenous dihydroergotamine therapy for intractable migraine.
    Headache, 2010, Volume: 50, Issue:5

    Topics: Adolescent; Adult; Analgesics, Non-Narcotic; Dihydroergotamine; Female; Headache Disorders; Home Infusion Therapy; Humans; Infusions, Intravenous; Male; Migraine Disorders; Pain, Intractable; Prospective Studies; Young Adult

2010
MAP0004, orally inhaled DHE: a randomized, controlled study in the acute treatment of migraine.
    Headache, 2011, Volume: 51, Issue:4

    Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Analgesics, Non-Narcotic; Dihydroergotamine; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Placebo Effect; Treatment Outcome; Young Adult

2011
MAP0004, orally inhaled dihydroergotamine for acute treatment of migraine: efficacy of early and late treatments.
    Mayo Clinic proceedings, 2011, Volume: 86, Issue:10

    Topics: Administration, Inhalation; Adolescent; Adult; Dihydroergotamine; Female; Humans; Male; Middle Aged; Migraine Disorders; Patient Selection; Time Factors; Treatment Outcome; Vasoconstrictor Agents; Young Adult

2011
Efficacy and safety of MAP0004, orally inhaled DHE in treating migraines with and without allodynia.
    Headache, 2012, Volume: 52, Issue:1

    Topics: Administration, Inhalation; Adolescent; Adult; Aged; Analgesics, Non-Narcotic; Dihydroergotamine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hyperalgesia; Male; Middle Aged; Migraine Disorders; Pain Measurement; Surveys and Questionnaires; Treatment Outcome; Young Adult

2012
Lack of drug interaction between the migraine drug MAP0004 (orally inhaled dihydroergotamine) and a CYP3A4 inhibitor in humans.
    Cephalalgia : an international journal of headache, 2012, Volume: 32, Issue:2

    Topics: 14-alpha Demethylase Inhibitors; Administration, Inhalation; Adult; Chemistry, Pharmaceutical; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dihydroergotamine; Drug Interactions; Female; Humans; Ketoconazole; Male; Migraine Disorders; Vasoconstrictor Agents; Young Adult

2012
MT 300. Dihydroergotamine mesylate injection - POZEN.
    Drugs in R&D, 2003, Volume: 4, Issue:2

    Topics: Dihydroergotamine; Humans; Injections; Migraine Disorders; Nausea; Time Factors

2003
The PROMISE study: PROphylaxis of MIgraine with SEglor (dihydroergotamine mesilate) in French primary care.
    CNS drugs, 2004, Volume: 18, Issue:15

    Topics: Adolescent; Adult; Aged; Dihydroergotamine; Double-Blind Method; Humans; Male; Middle Aged; Migraine Disorders; Primary Health Care; Quality of Life; Time Factors; Treatment Outcome; Vasoconstrictor Agents

2004
Observations of the "carry-over effect" following successful termination of chronic migraine in the adolescent with short-term dihydroergotamine, dexamethasone and hydroxyzine: a pilot study.
    The journal of headache and pain, 2005, Volume: 6, Issue:1

    Topics: Administration, Oral; Adolescent; Adult; Age Factors; Anti-Inflammatory Agents; Brain; Chronic Disease; Dexamethasone; Dihydroergotamine; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Female; Headache Disorders; Histamine H1 Antagonists; Humans; Hydroxyzine; Infusions, Parenteral; Male; Migraine Disorders; Pilot Projects; Treatment Outcome; Vasoconstrictor Agents

2005
Dihydroergotamine for early and late treatment of migraine with cutaneous allodynia: an open-label pilot trial.
    Headache, 2007, Volume: 47, Issue:6

    Topics: Adult; Analgesics, Non-Narcotic; Dihydroergotamine; Humans; Hyperalgesia; Injections, Intramuscular; Male; Middle Aged; Migraine Disorders; Physical Stimulation; Pilot Projects; Time Factors; Treatment Outcome

2007
[Treatment of morning migraine. Clinical and biokinetic correlation of programmed-release dihydroergotamine].
    Presse medicale (Paris, France : 1983), 1984, Jun-23, Volume: 13, Issue:26

    Topics: Adolescent; Adult; Circadian Rhythm; Clinical Trials as Topic; Delayed-Action Preparations; Dihydroergotamine; Double-Blind Method; Female; Humans; Kinetics; Male; Middle Aged; Migraine Disorders; Solutions

1984
Ergot derivatives in the prophylaxis of migraine: a multicentric study with a timed-release dihydroergotamine formulation.
    Cephalalgia : an international journal of headache, 1983, Volume: 3 Suppl 1

    Topics: Adult; Clinical Trials as Topic; Delayed-Action Preparations; Dihydroergotamine; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Random Allocation; Recurrence

1983
Planned release dihydroergotamine in common migraine and "tension-vascular headache": multicentre clinical trial.
    Cephalalgia : an international journal of headache, 1983, Volume: 3 Suppl 1

    Topics: Adolescent; Adult; Clinical Trials as Topic; Delayed-Action Preparations; Dihydroergotamine; Female; Humans; Male; Middle Aged; Migraine Disorders; Vascular Headaches

1983
Efficacy, safety, and tolerability of dihydroergotamine nasal spray as monotherapy in the treatment of acute migraine. Dihydroergotamine Nasal Spray Multicenter Investigators.
    Headache, 1995, Volume: 35, Issue:4

    Topics: Acute Disease; Adolescent; Adult; Dihydroergotamine; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Nausea; Time Factors

1995
Comparison of dihydroergotamine with metoclopramide versus meperidine with promethazine in the treatment of acute migraine.
    Headache, 1995, Volume: 35, Issue:5

    Topics: Acute Disease; Adult; Ambulatory Care; Dihydroergotamine; Double-Blind Method; Drug Combinations; Female; Humans; Male; Meperidine; Metoclopramide; Middle Aged; Migraine Disorders; Promethazine; Prospective Studies

1995
Dihydroergotamine nasal spray for the acute treatment of migraine.
    Neurology, 1994, Volume: 44, Issue:3 Pt 1

    Topics: Administration, Intranasal; Adolescent; Adult; Dihydroergotamine; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders

1994
Concomitant administration of antiemetics is not necessary with intramuscular dihydroergotamine.
    The American journal of emergency medicine, 1994, Volume: 12, Issue:2

    Topics: Acute Disease; Adolescent; Adult; Aged; Antiemetics; Child; Dihydroergotamine; Drug Therapy, Combination; Female; Humans; Incidence; Injections, Intramuscular; Male; Migraine Disorders; Nausea; Office Visits; Prospective Studies; Time Factors

1994
Subcutaneous sumatriptan in the acute treatment of migraine in patients using dihydroergotamine as prophylaxis. French Migraine Network Bordeaux-Lyon-Grenoble.
    Headache, 1993, Volume: 33, Issue:8

    Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Dihydroergotamine; Double-Blind Method; Drug Interactions; Female; Humans; Injections, Subcutaneous; Male; Middle Aged; Migraine Disorders; Sumatriptan

1993
[Treatment of migraine attacks: combination of dihydroergotamine tartrate and paracetamol in comparison with individual drugs and placebo].
    Medizinische Klinik (Munich, Germany : 1983), 1993, Nov-15, Volume: 88, Issue:11

    Topics: Acetaminophen; Adolescent; Adult; Aged; Dihydroergotamine; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Migraine Disorders; Pain Measurement

1993
A double-blind study of subcutaneous dihydroergotamine vs subcutaneous sumatriptan in the treatment of acute migraine.
    Archives of neurology, 1996, Volume: 53, Issue:2

    Topics: Acute Disease; Adolescent; Adult; Aged; Analgesics, Non-Narcotic; Dihydroergotamine; Double-Blind Method; Female; Humans; Injections, Subcutaneous; Male; Middle Aged; Migraine Disorders; Prospective Studies; Recurrence; Serotonin Receptor Agonists; Sumatriptan

1996
[Calcium carbasalate-metoclopramide combination versus dihydroergotamine in the treatment of migraine attacks].
    Pathologie-biologie, 1995, Volume: 43, Issue:9

    Topics: Administration, Oral; Adolescent; Adult; Analgesics, Non-Narcotic; Cross-Sectional Studies; Dihydroergotamine; Dopamine Antagonists; Double-Blind Method; Female; Humans; Male; Metoclopramide; Middle Aged; Migraine Disorders; Placebos

1995
A comparison of subcutaneous sumatriptan and dihydroergotamine nasal spray in the acute treatment of migraine.
    Neurology, 1996, Volume: 47, Issue:2

    Topics: Administration, Intranasal; Adult; Dihydroergotamine; Double-Blind Method; Female; Humans; Injections, Subcutaneous; Male; Middle Aged; Migraine Disorders; Sumatriptan

1996
Human pharmacokinetics of dihydroergotamine administered by nasal spray.
    Clinical pharmacology and therapeutics, 1996, Volume: 60, Issue:3

    Topics: Acute Disease; Administration, Intranasal; Adult; Analgesics, Non-Narcotic; Area Under Curve; Biological Availability; Dihydroergotamine; Dose-Response Relationship, Drug; Female; Humans; Injections, Intramuscular; Linear Models; Male; Middle Aged; Migraine Disorders; Reference Values; Rhinitis

1996
Acute treatment of migraine with dihydroergotamine nasal spray. Dihydroergotamine Working Group.
    Archives of neurology, 1996, Volume: 53, Issue:12

    Topics: Acute Disease; Administration, Intranasal; Adolescent; Adult; Aged; Dihydroergotamine; Double-Blind Method; Female; Hallucinations; Humans; Male; Middle Aged; Migraine Disorders; Nausea; Placebos; Self Administration

1996
Oral dihydroergotamine for therapy-resistant migraine attacks in children.
    Pediatric neurology, 1997, Volume: 16, Issue:2

    Topics: Administration, Oral; Analgesics, Non-Narcotic; Child; Cross-Over Studies; Dihydroergotamine; Double-Blind Method; Drug Resistance; Female; Humans; Male; Migraine Disorders; Retreatment; Treatment Outcome

1997
Double-blind, multicenter trial to compare the efficacy of intramuscular dihydroergotamine plus hydroxyzine versus intramuscular meperidine plus hydroxyzine for the emergency department treatment of acute migraine headache.
    Annals of emergency medicine, 1998, Volume: 32, Issue:2

    Topics: Acute Disease; Adolescent; Adult; Analgesics, Non-Narcotic; Analgesics, Opioid; Antiemetics; Dihydroergotamine; Double-Blind Method; Drug Combinations; Emergency Service, Hospital; Female; Follow-Up Studies; Humans; Hydroxyzine; Injections, Intramuscular; Male; Meperidine; Middle Aged; Migraine Disorders; Nausea; Pain Measurement; Prospective Studies; Time Factors

1998
Comparing dihydroergotamine mesylate and sumatriptan in the management of acute migraine. A retrospective cost-efficacy analysis.
    PharmacoEconomics, 1996, Volume: 10, Issue:1

    Topics: Adolescent; Adult; Aged; Cost-Benefit Analysis; Dihydroergotamine; Humans; Middle Aged; Migraine Disorders; Retrospective Studies; Sumatriptan; Vasoconstrictor Agents

1996
A clinical comparison of sumatriptan nasal spray and dihydroergotamine nasal spray in the acute treatment of migraine.
    International journal of clinical practice, 2000, Volume: 54, Issue:5

    Topics: Adult; Aged; Belgium; Cross-Over Studies; Dihydroergotamine; Double-Blind Method; Female; France; Humans; Male; Middle Aged; Migraine Disorders; Portugal; Sumatriptan; Switzerland; Vasoconstrictor Agents

2000
Dihydroergotamine nasal spray in the treatment of acute migraine.
    Headache, 1998, Volume: 38, Issue:8

    Topics: Acute Disease; Administration, Intranasal; Adult; Analgesics, Non-Narcotic; Dihydroergotamine; Double-Blind Method; Female; Humans; Male; Migraine Disorders; Nebulizers and Vaporizers; Treatment Outcome

1998
[Management of migraine using acupuncture in a double-blind study].
    Die Medizinische Welt, 1978, Apr-21, Volume: 29, Issue:16

    Topics: Acupuncture Therapy; Adult; Clinical Trials as Topic; Dihydroergotamine; Double-Blind Method; Female; Humans; Male; Migraine Disorders

1978
Dihydroergokryptine versus dihydroergotamine in migraine prophylaxis: a double-blind clinical trial.
    Cephalalgia : an international journal of headache, 1991, Volume: 11, Issue:3

    Topics: Adult; Analgesics; Dihydroergotamine; Dihydroergotoxine; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Time Factors

1991
[Flunarizine and dihydroergotamine in the treatment of migraine in children].
    Anales espanoles de pediatria, 1990, Volume: 32, Issue:3

    Topics: Age Factors; Child; Child, Preschool; Dihydroergotamine; Dose-Response Relationship, Drug; Flunarizine; Humans; Migraine Disorders; Parents

1990
[Dihydroergotamine as a nasal spray in the therapy of migraine attacks. Efficacy and tolerance].
    Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis, 1990, Aug-02, Volume: 79, Issue:31-32

    Topics: Administration, Intranasal; Adult; Aged; Aged, 80 and over; Child; Dihydroergotamine; Drug Evaluation; Female; Humans; Male; Middle Aged; Migraine Disorders; Multicenter Studies as Topic; Nebulizers and Vaporizers

1990
A comparative trial of three agents in the treatment of acute migraine headache.
    Annals of emergency medicine, 1990, Volume: 19, Issue:10

    Topics: Adult; Chlorpromazine; Dihydroergotamine; Emergencies; Follow-Up Studies; Humans; Infusions, Intravenous; Lidocaine; Migraine Disorders; Pain Measurement

1990
DHE-45 for acute migraine.
    Neurology, 1989, Volume: 39, Issue:10

    Topics: Acute Disease; Clinical Trials as Topic; Dihydroergotamine; Humans; Migraine Disorders; Research Design

1989
[Double blind study of migraine therapy with etilefrine pivalate].
    Arzneimittel-Forschung, 1985, Volume: 35, Issue:7

    Topics: Adult; Aged; Clinical Trials as Topic; Dihydroergotamine; Double-Blind Method; Etilefrine; Female; Humans; Male; Middle Aged; Migraine Disorders; Phenylephrine; Random Allocation; Time Factors

1985
Combined low-dose acetylsalicylic acid and dihydroergotamine in migraine prophylaxis. A double-blind, placebo-controlled crossover study.
    Cephalalgia : an international journal of headache, 1988, Volume: 8, Issue:3

    Topics: Adolescent; Adult; Aged; Aspirin; Dihydroergotamine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Female; Humans; Male; Middle Aged; Migraine Disorders; Placebos

1988
[Dihydroergotamine and flunarizine in the prevention of migraine. A comparative double-blind study].
    Fortschritte der Medizin, 1988, Jan-20, Volume: 106, Issue:2

    Topics: Adult; Clinical Trials as Topic; Delayed-Action Preparations; Dihydroergotamine; Double-Blind Method; Female; Flunarizine; Humans; Male; Middle Aged; Migraine Disorders

1988
Dihydroergotamine nasal spray during migraine attacks. A double-blind crossover study with placebo.
    Cephalalgia : an international journal of headache, 1987, Volume: 7, Issue:2

    Topics: Administration, Intranasal; Adolescent; Adult; Clinical Trials as Topic; Dihydroergotamine; Double-Blind Method; Female; Humans; Male; Migraine Disorders

1987
Prevention of migraine attacks through the use of dihydroergotamine.
    International journal of clinical pharmacology research, 1986, Volume: 6, Issue:1

    Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Delayed-Action Preparations; Dihydroergotamine; Double-Blind Method; Humans; Middle Aged; Migraine Disorders; Random Allocation; Time Factors

1986
A controlled study of dihydroergotamine in the treatment of acute migraine headache.
    Headache, 1986, Volume: 26, Issue:4

    Topics: Clinical Trials as Topic; Dihydroergotamine; Humans; Migraine Disorders

1986
Repetitive intravenous dihydroergotamine as therapy for intractable migraine.
    Neurology, 1986, Volume: 36, Issue:7

    Topics: Adult; Aged; Chronic Disease; Clinical Trials as Topic; Diazepam; Dihydroergotamine; Female; Humans; Injections; Injections, Intravenous; Male; Middle Aged; Migraine Disorders; Suppositories; Time Factors

1986
[Prevention of migraine with retard dihydroergotamine. Results of a multicenter study in 643 patients].
    Fortschritte der Medizin, 1986, Nov-20, Volume: 104, Issue:43

    Topics: Clinical Trials as Topic; Delayed-Action Preparations; Dihydroergotamine; Female; Humans; Male; Migraine Disorders

1986
[Migraine prevention with dihydroergotamine].
    Fortschritte der Medizin, 1985, Nov-07, Volume: 103, Issue:41

    Topics: Adult; Clinical Trials as Topic; Delayed-Action Preparations; Dihydroergotamine; Double-Blind Method; Female; Humans; Middle Aged; Migraine Disorders; Random Allocation

1985

Other Studies

147 other study(ies) available for dihydroergotamine and Migraine Disorders

ArticleYear
Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D alpha, human 5-hydroxytryptamine1D beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamin
    Molecular pharmacology, 1996, Volume: 50, Issue:6

    Topics: Animals; Benzopyrans; Cattle; Cloning, Molecular; Glioma; HeLa Cells; Humans; Mice; Migraine Disorders; Propylamines; Protein Binding; Pyrimidines; Radioligand Assay; Receptors, Serotonin; Serotonin Receptor Agonists; Signal Transduction; Tritium; Tumor Cells, Cultured; Vasoconstrictor Agents

1996
Dihydroergotamine and triptan use to treat migraine during pregnancy and the risk of adverse pregnancy outcomes.
    Scientific reports, 2021, 09-29, Volume: 11, Issue:1

    Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Adolescent; Adult; Case-Control Studies; Child; Child, Preschool; Dihydroergotamine; Female; Follow-Up Studies; Humans; Infant; Infant, Low Birth Weight; Infant, Newborn; Migraine Disorders; Pregnancy; Premature Birth; Prospective Studies; Quebec; Tryptamines; Young Adult

2021
A new dihydroergotamine nasal spray (Trudhesa) for migraine.
    The Medical letter on drugs and therapeutics, 2021, 12-27, Volume: 63, Issue:1640

    Topics: Administration, Intranasal; Dihydroergotamine; Humans; Migraine Disorders; Nasal Sprays; Vasoconstrictor Agents

2021
Peripheral Nerve Blocks: A Tool for Inpatient Pediatric Status Migrainosus.
    Pediatric neurology, 2023, Volume: 138

    Topics: Child; Dihydroergotamine; Humans; Inpatients; Migraine Disorders; Pain; Peripheral Nerves; Retrospective Studies

2023
Observational Analysis of the Costs Associated with Acute Treatment of Breakthrough Migraine Attacks in Medicaid Patients Using Preventive Therapies.
    Advances in therapy, 2023, Volume: 40, Issue:3

    Topics: Antibodies, Monoclonal; Calcitonin Gene-Related Peptide; Dihydroergotamine; Humans; Medicaid; Migraine Disorders; Tryptamines

2023
Enhancing Outpatient Dihydroergotamine Infusion With Interdisciplinary Care to Treat Refractory Pediatric Migraine: Preliminary Outcomes From the Comprehensive Aggressive Migraine Protocol ("CAMP").
    Headache, 2020, Volume: 60, Issue:1

    Topics: Adolescent; Ambulatory Care; Analgesics, Non-Narcotic; Aromatherapy; Child; Clinical Protocols; Combined Modality Therapy; Dihydroergotamine; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Massage; Migraine Disorders; Outcome Assessment, Health Care; Outpatient Clinics, Hospital; Pilot Projects; Psychotherapy; Retrospective Studies; Schools; Social Support

2020
Could inhaled drug formulations be the future of acute migraine treatment?
    Therapeutic delivery, 2019, Volume: 10, Issue:10

    Topics: Administration, Inhalation; Administration, Intranasal; Blood-Brain Barrier; Dihydroergotamine; Dopamine Agonists; Humans; Metered Dose Inhalers; Migraine Disorders; Oxazolidinones; Serotonin 5-HT1 Receptor Agonists; Tryptamines

2019
Implementation of an Intravenous Dihydroergotamine Protocol for Refractory Migraine in Children.
    Headache, 2020, Volume: 60, Issue:8

    Topics: Administration, Intravenous; Adolescent; Analgesics, Non-Narcotic; Child; Clinical Protocols; Dihydroergotamine; Female; Humans; Male; Migraine Disorders; Outcome Assessment, Health Care; Retrospective Studies

2020
The status of intravenous dihydroergotamine for pediatric headache: Status migrainosus and beyond.
    Headache, 2021, Volume: 61, Issue:5

    Topics: Administration, Intravenous; Child; Dihydroergotamine; Headache; Humans; Migraine Disorders

2021
Everything old is new again.
    Headache, 2021, Volume: 61, Issue:8

    Topics: Adult; Calcitonin Gene-Related Peptide Receptor Antagonists; Dihydroergotamine; Humans; Migraine Disorders; Piperidines; Pyridines; Vasoconstrictor Agents

2021
Dihydroergotamine mesylate-loaded dissolving microneedle patch made of polyvinylpyrrolidone for management of acute migraine therapy.
    Journal of controlled release : official journal of the Controlled Release Society, 2017, Dec-28, Volume: 268

    Topics: Acute Pain; Analgesics, Non-Narcotic; Animals; Biological Availability; Dihydroergotamine; Drug Delivery Systems; Drug Liberation; Injections, Subcutaneous; Male; Microinjections; Migraine Disorders; Needles; Povidone; Rats, Hairless; Rats, Sprague-Dawley; Skin; Solubility; Swine

2017
Diagnosis and treatment of migraine in the patient with depression.
    Journal of the American Association of Nurse Practitioners, 2018, Volume: 30, Issue:11

    Topics: Comorbidity; Depression; Dihydroergotamine; Disease Management; Humans; Migraine Disorders; Practice Guidelines as Topic; Serotonin 5-HT1 Receptor Agonists

2018
Development and in vitro/in vivo evaluation of dihydroergotamine mesylate loaded maltodextrin-pullulan sublingual films.
    Drug development and industrial pharmacy, 2019, Volume: 45, Issue:6

    Topics: Administration, Sublingual; Animals; Biological Availability; Dihydroergotamine; Drug Compounding; Drug Evaluation, Preclinical; Drug Liberation; Excipients; Female; Glucans; Injections, Intravenous; Migraine Disorders; Polysaccharides; Rabbits; Solubility; Time Factors; Vasoconstrictor Agents

2019
Intravenous dihydroergotamine therapy for pediatric abdominal migraines.
    Clinical pediatrics, 2013, Volume: 52, Issue:10

    Topics: Adolescent; Dihydroergotamine; Female; Humans; Infusions, Intravenous; Male; Migraine Disorders; Vasoconstrictor Agents; Young Adult

2013
Treatment of acute migraine in the emergency department.
    Canadian family physician Medecin de famille canadien, 2014, Volume: 60, Issue:1

    Topics: Acetaminophen; Acute Disease; Analgesics, Non-Narcotic; Analgesics, Opioid; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antiemetics; Dexamethasone; Dihydroergotamine; Droperidol; Emergency Service, Hospital; Evidence-Based Emergency Medicine; Fluid Therapy; Haloperidol; Humans; Migraine Disorders; Serotonin 5-HT1 Receptor Agonists

2014
Is orally inhaled dihydroergotamine (DHE) equivalent in efficacy in migraine to intravenous DHE?
    Headache, 2014, Volume: 54, Issue:2

    Topics: Administration, Inhalation; Administration, Intravenous; Administration, Oral; Dihydroergotamine; Humans; Migraine Disorders; Treatment Outcome

2014
The Use of a Pediatric Migraine Practice Guideline in an Emergency Department Setting.
    Pediatric emergency care, 2016, Volume: 32, Issue:7

    Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Antiemetics; Dihydroergotamine; Diphenhydramine; Emergency Service, Hospital; Female; Guideline Adherence; Humans; Hypnotics and Sedatives; Ketorolac; Length of Stay; Male; Metoclopramide; Migraine Disorders; Pain Management; Pain Measurement; Practice Guidelines as Topic; Prochlorperazine; Treatment Outcome; Vasoconstrictor Agents

2016
Movement Disorders From the Use of Metoclopramide and Other Antiemetics in the Treatment of Migraine.
    Headache, 2016, Volume: 56, Issue:1

    Topics: Adult; Dihydroergotamine; Dopamine Agonists; Dopamine D2 Receptor Antagonists; Expert Testimony; Female; Humans; Metoclopramide; Migraine Disorders; Movement Disorders

2016
Cerebral reactivity in migraine patients measured with functional near-infrared spectroscopy.
    European journal of medical research, 2015, Dec-08, Volume: 20

    Topics: Adult; Analgesics, Non-Narcotic; Cerebrovascular Circulation; Dihydroergotamine; Female; Humans; Magnesium Sulfate; Male; Middle Aged; Migraine Disorders; Self Report; Skin; Spectroscopy, Near-Infrared; Valproic Acid; Vasoconstrictor Agents

2015
Comment: Outcomes of migraine therapy with IV dihydroergotamine.
    Neurology, 2016, Mar-01, Volume: 86, Issue:9

    Topics: Dihydroergotamine; Female; Headache; Humans; Male; Migraine Disorders

2016
Exacerbation of headache during dihydroergotamine for chronic migraine does not alter outcome.
    Neurology, 2016, Mar-01, Volume: 86, Issue:9

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; California; Causality; Chronic Disease; Comorbidity; Dihydroergotamine; Female; Headache; Humans; Incidence; Injections, Intravenous; Male; Middle Aged; Migraine Disorders; Retrospective Studies; Risk Factors; Treatment Outcome; Vasoconstrictor Agents; Young Adult

2016
Ictal lack of binding to brain parenchyma suggests integrity of the blood-brain barrier for 11C-dihydroergotamine during glyceryl trinitrate-induced migraine.
    Brain : a journal of neurology, 2016, Volume: 139, Issue:Pt 7

    Topics: Adult; Blood-Brain Barrier; Dihydroergotamine; Female; Humans; Male; Middle Aged; Migraine Disorders; Nitroglycerin; Positron-Emission Tomography; Vasoconstrictor Agents; Vasodilator Agents

2016
Aprepitant for the management of nausea with inpatient IV dihydroergotamine.
    Neurology, 2016, Oct-11, Volume: 87, Issue:15

    Topics: Administration, Intravenous; Administration, Oral; Analgesics, Non-Narcotic; Antiemetics; Aprepitant; Dihydroergotamine; Humans; Inpatients; Migraine Disorders; Morpholines; Nausea; Prospective Studies; Retrospective Studies; Treatment Outcome

2016
Inpatient Pediatric Migraine Treatment: Does Choice of Abortive Therapy Affect Length of Stay?
    The Journal of pediatrics, 2016, Volume: 179

    Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Cohort Studies; Dihydroergotamine; Dopamine Antagonists; Female; Hospitalization; Humans; Length of Stay; Male; Migraine Disorders; Retrospective Studies

2016
Journal Club: Exacerbation of headache during dihydroergotamine for chronic migraine does not alter outcome.
    Neurology, 2016, Oct-18, Volume: 87, Issue:16

    Topics: Analgesics, Non-Narcotic; Dihydroergotamine; Headache; Humans; Migraine Disorders

2016
Safety of domperidone in treating nausea associated with dihydroergotamine infusion and headache.
    Neurology, 2016, Dec-13, Volume: 87, Issue:24

    Topics: Adolescent; Adult; Aged; Antiemetics; Dihydroergotamine; Domperidone; Female; Headache; Humans; Male; Middle Aged; Migraine Disorders; Nausea; Prospective Studies; Retrospective Studies; Young Adult

2016
Inpatient treatment of status migraine with dihydroergotamine in children and adolescents.
    Headache, 2009, Volume: 49, Issue:1

    Topics: Adolescent; Analgesics, Non-Narcotic; Child; Dihydroergotamine; Female; Humans; Inpatients; Male; Migraine Disorders; Treatment Outcome

2009
Drug dependence associated with triptans and ergot derivatives: a case/non-case study.
    European journal of clinical pharmacology, 2010, Volume: 66, Issue:4

    Topics: Claviceps; Dihydroergotamine; Ergotamine; Humans; Migraine Disorders; Oxazolidinones; Piperidines; Pyrrolidines; Risk; Substance-Related Disorders; Sumatriptan; Tryptamines

2010
Migraine: its treatment with dihydroergotamine (D.H.E. 45).
    The Ohio State medical journal, 1947, Volume: 43, Issue:9

    Topics: Dihydroergotamine; Humans; Migraine Disorders

1947
Dihydroergotamine (D.H.E. 45), a new and effective drug in the treatment of migraine.
    Rocky Mountain medical journal, 1946, Volume: 43, Issue:11

    Topics: Claviceps; Dihydroergotamine; Ergonovine; Ergot Alkaloids; Migraine Disorders

1946
Migraine headache; treatment of 51 patients with dihydroergotamine.
    The Medical annals of the District of Columbia, 1947, Volume: 16, Issue:1

    Topics: Dihydroergotamine; Humans; Migraine Disorders; Vasoconstrictor Agents

1947
DHE repression of ATP-mediated sensitization of trigeminal ganglion neurons.
    Headache, 2010, Volume: 50, Issue:9

    Topics: Adenosine Triphosphate; Animals; Calcitonin Gene-Related Peptide; Cells, Cultured; Dihydroergotamine; Down-Regulation; Female; Migraine Disorders; Neural Inhibition; Rats; Rats, Sprague-Dawley; Sensory Receptor Cells; Trigeminal Ganglion; Vasoconstrictor Agents

2010
Comparison of dihydroergotamine, ergotamine and other agents in the treatment of migraine.
    Permanente Foundation medical bulletin, 1946, Volume: 4

    Topics: Claviceps; Dihydroergotamine; Ergonovine; Ergot Alkaloids; Ergotamine; Migraine Disorders

1946
D.H.E. 45 (dihydroergotamine) a new drug in the treatment of migraine.
    Arizona medicine, 1946, Volume: 3

    Topics: Dihydroergotamine; Ergonovine; Ergot Alkaloids; Migraine Disorders

1946
Dihydroergotamine in the treatment of migraine; preliminary clinical observations.
    The Ohio State medical journal, 1945, Volume: 41

    Topics: Claviceps; Dihydroergotamine; Ergonovine; Ergot Alkaloids; Humans; Migraine Disorders

1945
DIHYDROERGOTAMINE and histamine for migraine.
    American professional pharmacist, 1946, Volume: 12

    Topics: Dihydroergotamine; Histamine; Humans; Migraine Disorders

1946
Commentary.
    Headache, 2011, Volume: 51, Issue:4

    Topics: Clinical Trials as Topic; Dihydroergotamine; Humans; Migraine Disorders; Serotonin 5-HT1 Receptor Agonists; Sumatriptan; Vasoconstrictor Agents

2011
Refractory caffeine and ergot-induced cervico-cerebral vasospasm and stroke treated with combined medical and endovascular approach.
    Neuroradiology, 2012, Volume: 54, Issue:1

    Topics: Adult; Caffeine; Cerebral Angiography; Dihydroergotamine; Drug Therapy, Combination; Female; Humans; Magnetic Resonance Angiography; Migraine Disorders; Nicardipine; Phosphodiesterase Inhibitors; Stents; Stroke; Vasoconstrictor Agents; Vasodilator Agents; Vasospasm, Intracranial

2012
Intravenous dihydroergotamine for inpatient management of refractory primary headaches.
    Neurology, 2011, Nov-15, Volume: 77, Issue:20

    Topics: Adult; Analgesics, Non-Narcotic; Cluster Headache; Dihydroergotamine; Disease Management; Drug Administration Schedule; Female; Follow-Up Studies; Headache Disorders, Primary; Humans; Injections, Intravenous; Inpatients; Male; Middle Aged; Migraine Disorders; Pain, Intractable; Treatment Outcome

2011
Headache currents commentary.
    Headache, 2012, Volume: 52, Issue:4

    Topics: Analgesics; Animals; Dihydroergotamine; Ergotamine; Headache; Humans; Methysergide; Migraine Disorders; Sumatriptan

2012
Headache in three new cases of Harlequin syndrome with accompanying pharmacological comparison with migraine.
    Journal of neurology, neurosurgery, and psychiatry, 2012, Volume: 83, Issue:6

    Topics: Adult; Aged; Autonomic Nervous System Diseases; Diagnosis, Differential; Dihydroergotamine; Ergotamine; Female; Flushing; Headache; Humans; Hypohidrosis; Middle Aged; Migraine Disorders; Nitroglycerin; Sumatriptan; Vasoconstrictor Agents; Vasodilator Agents

2012
The antimigraine 5-HT 1B/1D receptor agonists, sumatriptan, zolmitriptan and dihydroergotamine, attenuate pain-related behaviour in a rat model of trigeminal neuropathic pain.
    British journal of pharmacology, 2002, Volume: 137, Issue:8

    Topics: Animals; Dihydroergotamine; Disease Models, Animal; Male; Migraine Disorders; Oxazolidinones; Pain; Pain Threshold; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Sumatriptan; Trigeminal Nerve Diseases; Tryptamines

2002
Variations among emergency departments in the treatment of benign headache.
    Annals of emergency medicine, 2003, Volume: 41, Issue:1

    Topics: Adolescent; Adult; Aged; Algorithms; Analgesics, Non-Narcotic; Analgesics, Opioid; Antiemetics; Binomial Distribution; Cohort Studies; Confidence Intervals; Dihydroergotamine; Diphenhydramine; Drug Therapy, Combination; Emergency Service, Hospital; Female; Headache; Health Maintenance Organizations; Hospitals, Rural; Hospitals, University; Humans; Male; Meperidine; Middle Aged; Migraine Disorders; Practice Guidelines as Topic; Prochlorperazine; Retrospective Studies; Tension-Type Headache; United States

2003
Dysphonia associated with carotidynia and migraine responding to dihydroergotamine.
    Headache, 2003, Volume: 43, Issue:1

    Topics: Carotid Arteries; Dihydroergotamine; Female; Humans; Middle Aged; Migraine Disorders; Neck Pain; Recurrence; Voice Disorders

2003
Agonist actions of dihydroergotamine at 5-HT2B and 5-HT2C receptors and their possible relevance to antimigraine efficacy.
    British journal of pharmacology, 2003, Volume: 140, Issue:2

    Topics: Amphetamines; Animals; Binding, Competitive; Cell Line; Cyclic GMP; Dihydroergotamine; Humans; Inositol Phosphates; Iodine Radioisotopes; Kinetics; Migraine Disorders; Radioligand Assay; Receptor, Serotonin, 5-HT2B; Receptor, Serotonin, 5-HT2C; Serotonin 5-HT2 Receptor Agonists; Serotonin Receptor Agonists; Time Factors; Treatment Outcome

2003
[Ergotamine-caffeine and dihydroergotamine-caffeine in migraine therapy].
    Ugeskrift for laeger, 1952, Aug-21, Volume: 114, Issue:34

    Topics: Caffeine; Dihydroergotamine; Drug Combinations; Ergot Alkaloids; Ergotamine; Humans; Migraine Disorders; Oxytocics

1952
The action of ergotamine on the intracranial venous pressure and on the cerebral venous outflow of the dog.
    British journal of pharmacology and chemotherapy, 1957, Volume: 12, Issue:2

    Topics: Animals; Brain; Cerebral Veins; Cerebrovascular Circulation; Dihydroergotamine; Dogs; Ergot Alkaloids; Ergotamine; Hypertension; Intracranial Pressure; Migraine Disorders; Vasoconstriction; Vasoconstrictor Agents; Venous Pressure

1957
Preventive treatment of migraine with dihydroergotamine.
    The Practitioner, 1958, Volume: 181, Issue:1085

    Topics: Amides; Dihydroergotamine; Humans; Migraine Disorders

1958
[Treatment of migraine patients with inhalation of dihydroergotamine].
    Ugeskrift for laeger, 1962, Mar-30, Volume: 124

    Topics: Administration, Inhalation; Dihydroergotamine; Humans; Migraine Disorders

1962
[Efficacy of dihydroergotamine in ophthalmic hemicrania and glaucoma].
    Bollettino d'oculistica, 1950, Volume: 29, Issue:4

    Topics: Dihydroergotamine; Ergot Alkaloids; Eye; Glaucoma; Headache; Humans; Migraine Disorders

1950
[Treatment of migraine by dihydroergotamine].
    Paris medical, 1950, Nov-11, Volume: 40, Issue:42

    Topics: Dihydroergotamine; Ergonovine; Ergot Alkaloids; Humans; Migraine Disorders

1950
Headaches that could spell trouble.
    Consumer reports, 2004, Volume: 69, Issue:6

    Topics: Dihydroergotamine; Headache; Humans; Migraine Disorders; Sumatriptan

2004
Further experience with dihydroergotamine methanesulfonate in the treatment of migraine; with a note on the use of cafergone.
    Annals of western medicine and surgery, 1949, Volume: 3, Issue:11

    Topics: Claviceps; Dihydroergotamine; Ergonovine; Ergot Alkaloids; Humans; Migraine Disorders

1949
Efficacy of intravenous diphenhydramine versus intravenous DHE-45 in the treatment of severe migraine headache.
    Current pain and headache reports, 2005, Volume: 9, Issue:1

    Topics: Adolescent; Adult; Aged; Analgesics, Non-Narcotic; Antiemetics; Dihydroergotamine; Diphenhydramine; Drug Therapy, Combination; Female; Histamine H1 Antagonists; Humans; Injections, Intravenous; Male; Metoclopramide; Middle Aged; Migraine Disorders; Nausea

2005
Evaluation of the anti-emetic potential of anti-migraine drugs to prevent resiniferatoxin-induced emesis in Suncus murinus (house musk shrew).
    European journal of pharmacology, 2005, Jan-31, Volume: 508, Issue:1-3

    Topics: Animals; Antiemetics; Butanols; Capsaicin; Cyclooxygenase Inhibitors; Dihydroergotamine; Diphenhydramine; Diterpenes; Domperidone; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Humans; Indomethacin; Malates; Methysergide; Metoclopramide; Migraine Disorders; Ondansetron; Piperidines; Ruthenium Red; Scopolamine; Serotonin Antagonists; Serotonin Receptor Agonists; Shrews; Sumatriptan; Time Factors; Tropanes; Vomiting

2005
Successful treatment of status migrainosus after electroconvulsive therapy with dihydroergotamine.
    Headache, 2005, Volume: 45, Issue:4

    Topics: Dihydroergotamine; Electroconvulsive Therapy; Female; Humans; Middle Aged; Migraine Disorders; Vasoconstrictor Agents

2005
Patient information regarding subcutaneous self-administration of dihydroergotamine (DHE).
    Headache, 2007, Volume: 47, Issue:5

    Topics: Analgesics, Non-Narcotic; Dihydroergotamine; Humans; Injections, Subcutaneous; Migraine Disorders; Self Administration

2007
Triptans: actions and reactions.
    Headache, 2008, Volume: 48, Issue:4

    Topics: Administration, Cutaneous; Administration, Oral; Adult; Analgesics, Non-Narcotic; Dihydroergotamine; Female; Herpes Simplex; Herpesvirus 2, Human; Humans; Migraine Disorders; Neuralgia, Postherpetic; Pyrrolidines; Serotonin Receptor Agonists; Skin; Sumatriptan; Tryptamines

2008
Possible iatrogenic bilateral cerebral ischemic infarcts in a woman with vasculitis.
    The journal of headache and pain, 2008, Volume: 9, Issue:3

    Topics: Adult; Analgesics, Non-Narcotic; Cerebral Angiography; Cerebral Infarction; Diffusion Magnetic Resonance Imaging; Dihydroergotamine; Female; Humans; Migraine Disorders; Vasculitis

2008
[What is safe in the treatment of headache?].
    Der Internist, 1981, Volume: 22, Issue:12

    Topics: Anti-Anxiety Agents; Benzodiazepines; Cerebrovascular Disorders; Cluster Headache; Delayed-Action Preparations; Dihydroergotamine; Dihydroergotoxine; Headache; Humans; Methysergide; Migraine Disorders; Vascular Headaches

1981
Effects on arterial receptors of ergot derivatives used in migraine.
    Advances in neurology, 1982, Volume: 33

    Topics: Animals; Cattle; Dihydroergotamine; Dogs; Dose-Response Relationship, Drug; Ergotamines; Humans; In Vitro Techniques; Migraine Disorders; Muscle, Smooth, Vascular; Norepinephrine; Phentolamine; Pizotyline; Receptors, Adrenergic, alpha; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Vasoconstrictor Agents; Vasomotor System

1982
[Headache in children].
    Deutsche medizinische Wochenschrift (1946), 1984, Dec-14, Volume: 109, Issue:50

    Topics: Brain Neoplasms; Child; Child, Preschool; Contusions; Dihydroergotamine; Ergotamine; Headache; Humans; Hypertension, Renal; Migraine Disorders; Prognosis; Propranolol; Vascular Headaches

1984
Drug management of adult vascular headaches (migraine and cluster headache): Part I--Treatment of the acute attack.
    Iowa medicine : journal of the Iowa Medical Society, 1984, Volume: 74, Issue:11

    Topics: Cluster Headache; Dihydroergotamine; Ergotamine; Humans; Metoclopramide; Migraine Disorders; Vascular Headaches

1984
On the treatment of migraine. Pharmacokinetic-pharmacodynamic relationships for a programmed release formulation of dihydroergotamine administered orally in the human.
    Cephalalgia : an international journal of headache, 1983, Volume: 3 Suppl 1

    Topics: Administration, Oral; Adult; Biological Availability; Chemical Phenomena; Chemistry; Delayed-Action Preparations; Dihydroergotamine; Humans; Kinetics; Male; Migraine Disorders

1983
Menstrual migraine: intermittent prophylaxis with a timed-release pharmacological formulation of dihydroergotamine.
    Cephalalgia : an international journal of headache, 1983, Volume: 3 Suppl 1

    Topics: Adult; Delayed-Action Preparations; Dihydroergotamine; Female; Humans; Menstruation; Migraine Disorders; Time Factors

1983
Progress in migraine: treatment with dihydroergotamine-retard.
    Cephalalgia : an international journal of headache, 1983, Volume: 3 Suppl 1

    Topics: Delayed-Action Preparations; Dihydroergotamine; Female; Humans; Male; Migraine Disorders

1983
DHE retard for prophylactic therapy of migraine: efficacy and tolerability.
    Cephalalgia : an international journal of headache, 1983, Volume: 3 Suppl 1

    Topics: Adolescent; Adult; Delayed-Action Preparations; Dihydroergotamine; Drug Tolerance; Female; Humans; Male; Middle Aged; Migraine Disorders

1983
Clinical pharmacological aspects of dihydroergotamine timed release: activity on monoamine venospasm.
    Cephalalgia : an international journal of headache, 1983, Volume: 3 Suppl 1

    Topics: Adult; Delayed-Action Preparations; Dihydroergotamine; Female; Hand; Humans; Male; Middle Aged; Migraine Disorders; Norepinephrine; Serotonin; Spasm; Venous Pressure

1983
Pharmacology of arteriovenous anastomoses.
    Advances in neurology, 1982, Volume: 33

    Topics: Animals; Arteriovenous Anastomosis; Cats; Cerebrovascular Circulation; Dihydroergotamine; Ergotamine; Humans; Methylamines; Methysergide; Migraine Disorders; Sympathomimetics

1982
Antimigraine drugs and cranial arteriovenous shunting in the cat.
    Neurology, 1980, Volume: 30, Issue:7 Pt 1

    Topics: Animals; Arteriovenous Shunt, Surgical; Blood Gas Analysis; Carotid Arteries; Cats; Cerebrovascular Circulation; Dihydroergotamine; Ergotamine; Migraine Disorders; Oxygen; Skull

1980
[Need for gastric acidification in the treatment of abdominal migraine. Results of a multicenter study on the association of Séglor retard and Vagosérine].
    Medecine & chirurgie digestives, 1980, Volume: 9, Issue:6

    Topics: Adult; Aged; Dihydroergotamine; Drug Combinations; Female; Glutamates; Humans; Male; Middle Aged; Migraine Disorders; Papain; Physostigmine

1980
Management of migraine.
    Drug and therapeutics bulletin, 1981, Aug-28, Volume: 19, Issue:18

    Topics: Analgesics; Dihydroergotamine; Ergotamine; Humans; Migraine Disorders

1981
[Complications in the treatment of migraine with ergotamine and its derivatives].
    Wiadomosci lekarskie (Warsaw, Poland : 1960), 1981, May-01, Volume: 34, Issue:9

    Topics: Adult; Dihydroergotamine; Ergotamine; Ergotism; Female; Humans; Ischemia; Leg; Migraine Disorders; Vasoconstrictor Agents

1981
Dihydroergotamine nasal spray.
    Neurology, 1995, Volume: 45, Issue:2

    Topics: Administration, Intranasal; Bias; Controlled Clinical Trials as Topic; Dihydroergotamine; Humans; Migraine Disorders; Pain Measurement; Reproducibility of Results; Research Design

1995
Drugs for migraine.
    The Medical letter on drugs and therapeutics, 1995, Mar-03, Volume: 37, Issue:943

    Topics: Adrenergic beta-Antagonists; Analgesics; Dihydroergotamine; Humans; Migraine Disorders; Sumatriptan

1995
Practice parameter: appropriate use of ergotamine tartrate and dihydroergotamine in the treatment of migraine and status migrainosus (summary statement). Report of the Quality Standards Subcommittee of the American Academy of Neurology.
    Neurology, 1995, Volume: 45, Issue:3 Pt 1

    Topics: Dihydroergotamine; Ergotamine; Humans; Migraine Disorders

1995
Anti-migraine compounds fail to modulate the propagation of cortical spreading depression in the cat.
    European neurology, 1994, Volume: 34, Issue:1

    Topics: Analgesics; Animals; Aspirin; Cats; Cerebral Cortex; Clonazepam; Cortical Spreading Depression; Dihydroergotamine; Dizocilpine Maleate; Female; Halothane; Lidocaine; Metoprolol; Migraine Disorders; Receptors, N-Methyl-D-Aspartate; Regional Blood Flow; Ultrasonography, Doppler, Transcranial; Valproic Acid

1994
Home administration of intramuscular DHE for the treatment of acute migraine headache.
    Headache, 1994, Volume: 34, Issue:6

    Topics: Acute Disease; Adolescent; Adult; Dihydroergotamine; Female; Humans; Injections, Intramuscular; Male; Middle Aged; Migraine Disorders; Self Administration

1994
Recommendations for the emergency treatment of migraine headache.
    Journal of the Tennessee Medical Association, 1994, Volume: 87, Issue:2

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Antiemetics; Dexamethasone; Dihydroergotamine; Emergency Medical Services; Humans; Ketorolac; Migraine Disorders; Sumatriptan; Tolmetin

1994
Office-based treatment of acute migraine with dihydroergotamine mesylate.
    Headache, 1993, Volume: 33, Issue:9

    Topics: Acute Disease; Adolescent; Adult; Aged; Dihydroergotamine; Female; Humans; Injections, Intramuscular; Male; Middle Aged; Migraine Disorders; Office Visits

1993
[Improper equalization of sumatriptan with ergotamine and dihydroergotamine in the Drug Equivalency System].
    Nederlands tijdschrift voor geneeskunde, 1993, Apr-24, Volume: 137, Issue:17

    Topics: Dihydroergotamine; Ergotamine; Humans; Indoles; Migraine Disorders; Serotonin Receptor Agonists; Sulfonamides; Sumatriptan; Vasoconstrictor Agents

1993
The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats.
    Annals of neurology, 1993, Volume: 33, Issue:1

    Topics: Adolescent; Adult; Animals; Blood Vessels; Cats; Cerebrovascular Circulation; Dihydroergotamine; Female; Humans; Indoles; Laser-Doppler Flowmetry; Male; Middle Aged; Migraine Disorders; Neuropeptides; Sulfonamides; Sumatriptan; Trigeminal Ganglion; Vasoconstrictor Agents

1993
[Unjustified equalization of sumatriptan with ergotamine and dihydroergotamine in the Drug Equivalency System].
    Nederlands tijdschrift voor geneeskunde, 1993, Jun-12, Volume: 137, Issue:24

    Topics: Dihydroergotamine; Ergotamine; Humans; Indoles; Migraine Disorders; Serotonin Receptor Agonists; Sulfonamides; Sumatriptan; Therapeutic Equivalency; Vasoconstrictor Agents

1993
Dihydroergotamine local reactions reduced by normal saline.
    Neurology, 1993, Volume: 43, Issue:9

    Topics: Adult; Dihydroergotamine; Female; Humans; Migraine Disorders; Sodium Chloride

1993
Coexistence of migraine and idiopathic intracranial hypertension without papilledema.
    Neurology, 1996, Volume: 46, Issue:5

    Topics: Acetazolamide; Adolescent; Adult; Dihydroergotamine; Diuretics; Ergotamine; Female; Follow-Up Studies; Furosemide; Headache; Humans; Intracranial Pressure; Male; Middle Aged; Migraine Disorders; Obesity; Papilledema; Pseudotumor Cerebri; Sumatriptan

1996
Onset of neurologic deficits after treatment with dihydroergotamine in a patient with sagittal sinus thrombosis.
    Clinical neuropharmacology, 1996, Volume: 19, Issue:2

    Topics: Adult; Angiography; Dihydroergotamine; Fatal Outcome; Female; Humans; Intracranial Pressure; Migraine Disorders; Nervous System Diseases; Sinus Thrombosis, Intracranial; Tomography, X-Ray Computed; Vasoconstrictor Agents

1996
Serotonin syndrome complicating migraine pharmacotherapy.
    Cephalalgia : an international journal of headache, 1996, Volume: 16, Issue:5

    Topics: Adult; Autonomic Nervous System Diseases; Dihydroergotamine; Drug Synergism; Female; Gastrointestinal Diseases; Humans; Injections, Intravenous; Injections, Subcutaneous; Lithium; Mental Disorders; Migraine Disorders; Movement Disorders; Serotonin Receptor Agonists; Sumatriptan; Syndrome

1996
Effect of antimigraine drugs on dural blood flows and resistances and the responses to trigeminal stimulation.
    European journal of pharmacology, 1996, Sep-12, Volume: 311, Issue:2-3

    Topics: Animals; Blood Pressure; Carotid Arteries; Cats; Dihydroergotamine; Dose-Response Relationship, Drug; Heart Rate; Injections, Intravenous; Meningeal Arteries; Migraine Disorders; Regional Blood Flow; Sumatriptan; Trigeminal Ganglion; Vascular Resistance; Vasoconstrictor Agents

1996
Subcutaneous dihydroergotamine vs subcutaneous sumatriptan.
    Archives of neurology, 1996, Volume: 53, Issue:12

    Topics: Dihydroergotamine; Humans; Injections, Subcutaneous; Migraine Disorders; Sumatriptan

1996
Effectiveness of subcutaneous dihydroergotamine by home injection for migraine.
    Headache, 1996, Volume: 36, Issue:3

    Topics: Adult; Analgesics, Non-Narcotic; Dihydroergotamine; Female; Home Nursing; Humans; Injections, Subcutaneous; Male; Middle Aged; Migraine Disorders; Retrospective Studies; Self Administration

1996
Appropriate use of ergotamine tartrate and dihydroergotamine in the treatment of migraine: current perspectives.
    Headache, 1997, Volume: 37 Suppl 1

    Topics: Analgesics, Non-Narcotic; Contraindications; Dihydroergotamine; Ergotamine; Humans; Migraine Disorders; Practice Guidelines as Topic

1997
[The treatment of migraine].
    Revista de neurologia, 1997, Volume: 25, Issue:138

    Topics: Adrenergic beta-Antagonists; Amitriptyline; Calcium Channel Blockers; Dihydroergotamine; Ergotamine; Flunarizine; Humans; Methysergide; Migraine Disorders; Nicardipine; Nimodipine; Serotonin Antagonists; Serotonin Receptor Agonists; Sumatriptan; Vasoconstrictor Agents

1997
Agonist activity of antimigraine drugs at recombinant human 5-HT1A receptors: potential implications for prophylactic and acute therapy.
    Naunyn-Schmiedeberg's archives of pharmacology, 1997, Volume: 355, Issue:6

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Benzopyrans; Binding, Competitive; Cell Membrane; Cricetinae; Dihydroergotamine; Guanosine 5'-O-(3-Thiotriphosphate); Guinea Pigs; Humans; In Vitro Techniques; Indoles; Lisuride; Methysergide; Migraine Disorders; Piperazines; Piperidines; Pizotyline; Propranolol; Propylamines; Protein Binding; Pyridines; Pyrimidines; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Recombinant Proteins; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Sumatriptan; Tryptamines

1997
[Critical evaluation of "guidelines"].
    Praxis, 1998, Feb-04, Volume: 87, Issue:6

    Topics: Adult; Dihydroergotamine; Female; Humans; Migraine Disorders; Practice Guidelines as Topic; Quality Assurance, Health Care; Sumatriptan; Switzerland

1998
Coronary side-effect potential of current and prospective antimigraine drugs.
    Circulation, 1998, Jul-07, Volume: 98, Issue:1

    Topics: Adolescent; Adult; Aged; Angina Pectoris; Child; Coronary Vessels; Dihydroergotamine; Ergotamine; Female; Humans; In Vitro Techniques; Indoles; Male; Methysergide; Middle Aged; Migraine Disorders; Piperidines; Sulfonamides; Sumatriptan; Triazoles; Tryptamines; Vasoconstrictor Agents

1998
[Bilateral ischemic optic neuropathy secondary to acute ergotism].
    Journal francais d'ophtalmologie, 1998, Volume: 21, Issue:2

    Topics: Adult; Anti-Bacterial Agents; Dihydroergotamine; Ergotamine; Ergotism; Humans; Hypertension; Macrolides; Male; Migraine Disorders; Optic Neuropathy, Ischemic; Vasoconstrictor Agents; Visual Acuity

1998
New "triptans" and other drugs for migraine.
    The Medical letter on drugs and therapeutics, 1998, Oct-09, Volume: 40, Issue:1037

    Topics: Adrenergic beta-Antagonists; Amitriptyline; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents, Tricyclic; Calcium Channel Blockers; Dihydroergotamine; Drug Interactions; Ergotamine; Humans; Indoles; Methysergide; Migraine Disorders; Naproxen; Oxazoles; Oxazolidinones; Piperidines; Propranolol; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Sumatriptan; Time Factors; Timolol; Triazoles; Tryptamines; Valproic Acid; Vasoconstrictor Agents

1998
[Finger tip necroses after dihydroergotamine medication in limited systemic scleroderma].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 1998, Volume: 49, Issue:9

    Topics: Aged; Contraindications; Dihydroergotamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fingers; Humans; Migraine Disorders; Necrosis; Raynaud Disease; Risk Factors; Scleroderma, Systemic

1998
[Treatment of acute attacks of migraine by dihydergot: nasal aerosols].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 1999, Volume: 99, Issue:2

    Topics: Acute Disease; Adult; Aerosols; Analgesics, Non-Narcotic; Dihydroergotamine; Female; Humans; Male; Middle Aged; Migraine Disorders; Time Factors

1999
[Transformed migraine--chronic daily headache].
    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1999, Nov-30, Volume: 119, Issue:29

    Topics: Adult; Analgesics, Non-Narcotic; Chronic Disease; Dihydroergotamine; Female; Headache; Humans; Injections, Intravenous; Male; Middle Aged; Migraine Disorders; Patient Satisfaction; Terminology as Topic; Treatment Outcome; Vasoconstrictor Agents

1999
Transient global amnesia, migraine, thalamic infarct, dihydroergotamine, and sumatriptan.
    Headache, 2000, Volume: 40, Issue:4

    Topics: Amnesia, Transient Global; Brain Infarction; Dihydroergotamine; Female; Humans; Injections, Subcutaneous; Middle Aged; Migraine Disorders; Sumatriptan; Vasoconstrictor Agents

2000
[Migraine treatment].
    Deutsche medizinische Wochenschrift (1946), 2000, Mar-31, Volume: 125, Issue:13

    Topics: Acetaminophen; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Antiemetics; Aspirin; Dihydroergotamine; Drug Therapy, Combination; Ergotamine; Humans; Migraine Disorders; Serotonin Receptor Agonists; Severity of Illness Index; Vasoconstrictor Agents

2000
Sumatriptan nasal spray in the acute treatment of migraine: a review of clinical studies.
    Cephalalgia : an international journal of headache, 2000, Volume: 20, Issue:2

    Topics: Dihydroergotamine; Humans; Migraine Disorders; Nebulizers and Vaporizers; Sumatriptan; Vasoconstrictor Agents

2000
[Effect of migraine medications on monocyte chemotaxis] .
    Anaesthesiologie und Reanimation, 2000, Volume: 25, Issue:4

    Topics: Adult; Analgesics; Aspirin; Chemotaxis, Leukocyte; Dihydroergotamine; Humans; Immune Tolerance; Male; Metoclopramide; Metoprolol; Migraine Disorders; Propranolol; Sumatriptan

2000
[Pharmaco-epidemiological study on the prophylactic treatment of migraine. National inquiry on attitude to prescription practices by primary care physicians and neurologists in Franceø].
    Revue neurologique, 2000, Volume: 156, Issue:12

    Topics: Adrenergic beta-Antagonists; Dihydroergotamine; Family Practice; France; Humans; Migraine Disorders; Neurology; Physicians, Family; Surveys and Questionnaires; Telephone

2000
Sumatriptin vs dihydroergotamine: patient preference.
    International journal of clinical practice, 2001, Volume: 55, Issue:2

    Topics: Administration, Inhalation; Analgesics, Non-Narcotic; Dihydroergotamine; Humans; Migraine Disorders; Patient Satisfaction; Serotonin Receptor Agonists; Sumatriptan

2001
Status migrainosus in children and adolescents.
    Seminars in pediatric neurology, 2001, Volume: 8, Issue:1

    Topics: Adolescent; Child; Diagnosis, Differential; Dihydroergotamine; Drug Therapy, Combination; Female; Follow-Up Studies; Genetic Predisposition to Disease; Humans; Male; Meperidine; Methylprednisolone; Migraine Disorders; Prednisolone; Sumatriptan

2001
Sumatriptan by injection.
    Cephalalgia : an international journal of headache, 2001, Volume: 21 Suppl 1

    Topics: Clinical Trials as Topic; Dihydroergotamine; Dose-Response Relationship, Drug; Humans; Injections, Subcutaneous; Migraine Disorders; Sumatriptan; Treatment Outcome

2001
[Migraine and facial pain].
    La Revue du praticien, 2001, Oct-15, Volume: 51, Issue:16

    Topics: Adult; Analgesics; Analgesics, Non-Narcotic; Carbamazepine; Child; Diagnosis, Differential; Dihydroergotamine; Facial Pain; Female; Humans; Male; Methysergide; Middle Aged; Migraine Disorders; Oxygen Inhalation Therapy; Psychotherapy; Serotonin Antagonists; Sumatriptan; Time Factors; Trigeminal Neuralgia; Vasoconstrictor Agents

2001
[Migraine: a disease, not a symptom].
    La Revue du praticien, 2002, Jan-01, Volume: 52, Issue:1

    Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Analgesics; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Atenolol; Diagnosis, Differential; Dihydroergotamine; Flunarizine; GABA Agents; Humans; Indoramin; Methysergide; Migraine Disorders; Oxazolidinones; Serotonin Antagonists; Serotonin Receptor Agonists; Tryptamines; Valproic Acid; Vasoconstrictor Agents; Vasodilator Agents

2002
[Stellate ganglion block under EEG control in the treatment of complicated cervical migraine (author's transl)].
    Journal of neurology, 1975, Aug-01, Volume: 209, Issue:4

    Topics: Adult; Autonomic Nerve Block; Cinnarizine; Craniocerebral Trauma; Dihydroergotamine; Electroencephalography; Humans; Male; Migraine Disorders; Procaine; Pyrithioxin; Stellate Ganglion

1975
[Mechanism of action of drugs currently used in the prevention of migraine].
    Minerva medica, 1976, Jun-02, Volume: 67, Issue:28

    Topics: Adrenergic beta-Antagonists; Catecholamines; Cerebrovascular Circulation; Chemical Phenomena; Chemistry; Clonidine; Dihydroergotamine; Ergotamine; Histamine Release; Humans; Kinins; Methysergide; Migraine Disorders; Pizotyline; Serotonin Antagonists

1976
[Drug therapy of migraine and cluster headache].
    Deutsche medizinische Wochenschrift (1946), 1975, Jun-06, Volume: 100, Issue:23

    Topics: Analgesics; Barbiturates; Caffeine; Dihydroergotamine; Drug Synergism; Ergot Alkaloids; Headache; Histamine H1 Antagonists; Humans; Methysergide; Migraine Disorders; Vascular Headaches

1975
[Drug therapy for headache: (author's transl)].
    MMW, Munchener medizinische Wochenschrift, 1977, Apr-08, Volume: 119, Issue:14

    Topics: Analgesics; Anti-Inflammatory Agents; Antidepressive Agents; Clonidine; Dihydroergotamine; Ergotamine; Headache; Humans; Migraine Disorders; Neuralgia; Pizotyline; Sleep; Substance-Related Disorders; Tranquilizing Agents

1977
Cluster headache: relation to and comparison with migraine.
    Postgraduate medicine, 1979, Volume: 66, Issue:2

    Topics: Cluster Headache; Diagnosis, Differential; Dihydroergotamine; Ergotamine; Female; Humans; Male; Methysergide; Migraine Disorders; Prednisone; Vascular Headaches

1979
Potentiation and antagonism of serotonin effects on intracranial and extracranial vessels. Possible implications in migraine.
    Neurology, 1978, Volume: 28, Issue:1

    Topics: Animals; Arteries; Cats; Cerebral Arteries; Cyproheptadine; Dihydroergotamine; Drug Synergism; Ergotamine; Humans; In Vitro Techniques; Methysergide; Migraine Disorders; Pizotyline; Serotonin; Serotonin Antagonists; Vasoconstriction; Vasomotor System

1978
Migraine. Prophylactic drugs.
    Nursing mirror, 1977, Aug-11, Volume: 145, Issue:6

    Topics: Anticonvulsants; Clonidine; Cyproheptadine; Dihydroergotamine; Humans; Methysergide; Migraine Disorders; Pizotyline; Propranolol; Tranquilizing Agents

1977
[The long term use of dihydroergotamine (DHE-45) in migraine treatment (author's transl)].
    Masui. The Japanese journal of anesthesiology, 1978, Volume: 27, Issue:1

    Topics: Adult; Dihydroergotamine; Female; Hemodynamics; Humans; Male; Middle Aged; Migraine Disorders; Time Factors

1978
[Letter: Coronary spasm following ergotamine medication].
    MMW, Munchener medizinische Wochenschrift, 1975, Sep-05, Volume: 117, Issue:36

    Topics: Adult; Angina Pectoris; Coronary Disease; Coronary Vessels; Dihydroergotamine; Ergotamine; Headache; Humans; Male; Migraine Disorders

1975
[Iatrogenic ergotism].
    Revue medicale de Liege, 1977, Jan-15, Volume: 32, Issue:2

    Topics: Adult; Dihydroergotamine; Ergotamines; Ergotism; Female; Humans; Migraine Disorders

1977
Bilateral retinal hemorrhages and disk edema in migraine.
    American journal of ophthalmology, 1977, Volume: 84, Issue:4

    Topics: Adult; Belladonna Alkaloids; Child; Cyproheptadine; Dihydroergotamine; Female; Fluorescein Angiography; Humans; Male; Migraine Disorders; Papilledema; Radiography; Retinal Hemorrhage; Skull; Vomiting

1977
[The use of drugs in migraine].
    Minerva medica, 1976, Jun-02, Volume: 67, Issue:28

    Topics: Acetaminophen; Antiemetics; Aspirin; Clonidine; Dihydroergotamine; Ergotamine; Humans; Hypnotics and Sedatives; Methysergide; Migraine Disorders; Tranquilizing Agents

1976
Letter: Oral dihydroergotamine in management of cluster headache.
    British medical journal, 1976, Jan-10, Volume: 1, Issue:6001

    Topics: Administration, Oral; Dihydroergotamine; Ergotamines; Female; Humans; Middle Aged; Migraine Disorders

1976
Lack of effect of the antimigraine drugs, sumatriptan, ergotamine and dihydroergotamine on arteriovenous anastomotic shunting in the dura mater of the pig.
    British journal of pharmacology, 1992, Volume: 107, Issue:2

    Topics: Animals; Arteriovenous Anastomosis; Dihydroergotamine; Dura Mater; Ergotamine; Hemodynamics; Indoles; Microspheres; Migraine Disorders; Regional Blood Flow; Sulfonamides; Sumatriptan; Swine; Vasoconstrictor Agents

1992
5-Hydroxtryptamine1D receptor agonism predicts antimigraine efficacy.
    Headache, 1991, Volume: 31, Issue:4

    Topics: Adenylyl Cyclase Inhibitors; Amitriptyline; Animals; Cattle; Caudate Nucleus; Dihydroergotamine; Ergotamine; Indoles; Kinetics; Methysergide; Migraine Disorders; Radioligand Assay; Receptors, Serotonin; Serotonin; Sulfonamides; Sumatriptan; Vasoconstrictor Agents; Verapamil

1991
Evidence for 5-HT1B/1D receptors mediating the antimigraine effect of sumatriptan and dihydroergotamine.
    Cephalalgia : an international journal of headache, 1991, Volume: 11, Issue:4

    Topics: Animals; Blood Proteins; Calcitonin Gene-Related Peptide; Capillary Permeability; Cerebrovascular Circulation; Cranial Sinuses; Dihydroergotamine; Electric Stimulation; Indoles; Male; Mast Cells; Migraine Disorders; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Sulfonamides; Sumatriptan; Trigeminal Ganglion; Vasoconstrictor Agents

1991
The hospital management of severe migrainous headache.
    Headache, 1991, Volume: 31, Issue:10

    Topics: Adolescent; Adult; Aged; Child; Dihydroergotamine; Drug Therapy, Combination; Female; Humans; Indoles; Lidocaine; Male; Middle Aged; Migraine Disorders; Retrospective Studies; Sulfonamides; Sumatriptan

1991
A case of portal thrombosis arisen after treatment with dihydroergotamine.
    The Italian journal of gastroenterology, 1991, Volume: 23, Issue:4

    Topics: Adult; Dihydroergotamine; Female; Humans; Migraine Disorders; Portal Vein; Thrombosis; Time Factors

1991
Dihydroergotamine suppositories in a headache clinic.
    Headache, 1991, Volume: 31, Issue:7

    Topics: Dihydroergotamine; Headache; Humans; Migraine Disorders; Suppositories

1991
The antimigraine drugs ergotamine and dihydroergotamine are potent 5-HT1C receptor agonists in piglet choroid plexus.
    British journal of pharmacology, 1991, Volume: 104, Issue:1

    Topics: Animals; Binding, Competitive; Choroid Plexus; Dihydroergotamine; Ergolines; Ergotamine; In Vitro Techniques; Inositol Phosphates; Migraine Disorders; Piperazines; Receptors, Serotonin; Serotonin; Swine; Thermodynamics

1991
Ketorolac versus DHE and metoclopramide in the treatment of migraine headaches.
    Headache, 1991, Volume: 31, Issue:8

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Dihydroergotamine; Drug Therapy, Combination; Humans; Ketorolac; Metoclopramide; Migraine Disorders; Tolmetin

1991
Localization of 3H-dihydroergotamine-binding sites in the cat central nervous system: relevance to migraine.
    Annals of neurology, 1991, Volume: 29, Issue:1

    Topics: Animals; Autoradiography; Binding Sites; Cats; Central Nervous System; Dihydroergotamine; Female; Male; Migraine Disorders

1991
Claudication: an unusual side effect of DHE administration.
    Headache, 1991, Volume: 31, Issue:4

    Topics: Adult; Dihydroergotamine; Female; Humans; Intermittent Claudication; Middle Aged; Migraine Disorders; Pulse; Vascular Diseases

1991
Treatment of status migrainosus: the American experience.
    Headache, 1990, Volume: 30 Suppl 2

    Topics: Acute Disease; Algorithms; Analgesics; Contraindications; Dihydroergotamine; Drug Administration Schedule; Drug Tolerance; Humans; Migraine Disorders; Substance-Related Disorders; United States

1990
Abortive versus prophylactic treatment of migraine--a reappraisal.
    Headache, 1990, Volume: 30, Issue:4

    Topics: Dihydroergotamine; Humans; Migraine Disorders; Propranolol

1990
Haloperidol and lorazepam for the treatment of nausea and vomiting associated with the treatment of intractable migraine headaches.
    Archives of neurology, 1989, Volume: 46, Issue:7

    Topics: Adult; Dihydroergotamine; Female; Haloperidol; Humans; Lorazepam; Migraine Disorders; Nausea; Vomiting

1989
[Beta receptor blockers in migraine].
    Deutsche medizinische Wochenschrift (1946), 1985, Feb-01, Volume: 110, Issue:5

    Topics: Adrenergic beta-Antagonists; Anti-Anxiety Agents; Cinnarizine; Dihydroergotamine; Dose-Response Relationship, Drug; Flunarizine; Humans; Hypotension; Migraine Disorders; Time Factors

1985
[Antimigrainous agents. General considerations and treatment of the crisis].
    La Revue du praticien, 1986, Jan-21, Volume: 36, Issue:5

    Topics: Acupuncture Therapy; Amitriptyline; Analgesics; Anti-Anxiety Agents; Anti-Inflammatory Agents; Antiemetics; Caffeine; Dihydroergotamine; Ergotamine; Ergotamines; Humans; Migraine Disorders

1986
[Antimigrainous agents used in maintenance treatment].
    La Revue du praticien, 1986, Jan-21, Volume: 36, Issue:5

    Topics: Adrenergic beta-Antagonists; Amitriptyline; Aspirin; Benzoxepins; Calcium Channel Blockers; Cinnarizine; Clonidine; Dihydroergotamine; Flunarizine; Humans; Methysergide; Migraine Disorders; Pizotyline; Propranolol

1986
[Ergotismus as a consequence of migraine prevention].
    RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 1987, Volume: 146, Issue:4

    Topics: Adult; Chronic Disease; Dihydroergotamine; Ergotism; Female; Femoral Artery; Heparin; Humans; Ischemia; Leg; Migraine Disorders; Popliteal Artery; Thromboembolism

1987
IV dihydroergotamine therapy for migraine treatment.
    Annals of emergency medicine, 1988, Volume: 17, Issue:7

    Topics: Dihydroergotamine; Emergency Medicine; Humans; Injections, Intravenous; Migraine Disorders

1988
[Treatment of migraine attacks in children with dihydroergotamine Spofa and lysenyl].
    Ceskoslovenska pediatrie, 1986, Volume: 41, Issue:11

    Topics: Adolescent; Child; Dihydroergotamine; Electroencephalography; Ergolines; Female; Humans; Lisuride; Male; Migraine Disorders

1986
Emergency treatment of intractable migraine.
    Headache, 1986, Volume: 26, Issue:2

    Topics: Adult; Dexamethasone; Dihydroergotamine; Drug Therapy, Combination; Female; Humans; Male; Meperidine; Migraine Disorders; Pain, Intractable; Promethazine

1986
Ergotamine-induced colitis.
    Endoscopy, 1985, Volume: 17, Issue:4

    Topics: Colitis, Ulcerative; Dihydroergotamine; Female; Humans; Middle Aged; Migraine Disorders; Proctitis; Sigmoidoscopy; Suppositories; Time Factors

1985
[Ergotamine-induced disorders of the peripheral blood circulation--a case report].
    Rontgen-Blatter; Zeitschrift fur Rontgen-Technik und medizinisch-wissenschaftliche Photographie, 1985, Volume: 38, Issue:6

    Topics: Adult; Dihydroergotamine; Female; Humans; Ischemia; Leg; Migraine Disorders

1985
The management of migraine.
    Scottish medical journal, 1985, Volume: 30, Issue:4

    Topics: Clonidine; Diet; Dihydroergotamine; Female; Humans; Male; Methysergide; Migraine Disorders; Pizotyline; Propranolol

1985
[Retroperitoneal fibrosis and ergot derivatives. Ophthalmological adverse effects].
    Bulletin des societes d'ophtalmologie de France, 1974, Volume: 74, Issue:3

    Topics: Dihydroergotamine; Ergotamines; Humans; Male; Middle Aged; Migraine Disorders; Retroperitoneal Fibrosis

1974